Safety alerts
Drug lookup, recalls and shortages
Look up any drug for its FDA label, shortage status and recalls. Below: the recalls that matter most right now, every recall of the last 90 days and every drug in shortage.
New recall alerts
From the last 30 days, often days or weeks before they reach the FDA’s weekly records: the FDA’s own device recall alerts and safety advisories, companies’ recall announcements (drugs, devices, supplements, and foods contaminated with germs or lead), and the USDA’s meat and poultry alerts
-
Nov. 10, 2026Food contamination
Laub's Feeding & Cubing, Inc. Voluntary Recalls Grade A Mini Hay Cubes Because of Potential Clostridium Botulinum Contamination (opens in a new tab)
Laub’s Feeding and Cubing, Inc. of Beryl, Utah is voluntary recalling up 89 ton of Grade A Mini Hay Cubes sold from October 3, October 31 because the product has the potential to be contaminated with Clostridium botulinum, a bacterium that...
-
Nov. 10, 2026Food contamination
Family Farmstead Dairy Announces Recall of All Cheddar Cheese Products Because of Possible Health Risk (opens in a new tab)
Worcester, New York, Family Farmstead Dairy is recalling all cheddar cheese products because it has the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young...
Also posted about this recall
- Oct. 15, 2026 Family Farmstead Dairy Announces Recall of Raw Mild Cheddar Cheese Due to Potential E. coli O26:H11 and O45:H2 Contamination (opens in a new tab)
- Oct. 15, 2026 Family Farmstead Dairy Announces Recall of Raw Mild Cheddar Cheese Due to Potential E. coli O157:H7 Contamination (opens in a new tab)
-
Nov. 10, 2026FDA alert: most serious device problem
Early Alert: Intersurgical Inc. Removes 22mm Smoothbore breathing tubes and systems (opens in a new tab)
Intersurgical removes 22mm Smoothbore breathing tubes and systems because connectors may detach, causing ventilation loss, brain damage, or death.
-
Nov. 10, 2026FDA alert: most serious device problem
Early Alert: Arrow International Removes Products Containing Spring Wire Guide Components (opens in a new tab)
Spring Wire Guides containing hydrophilic coating may detach and release particles into the bloodstream, risking embolism.
-
Nov. 9, 2026FDA alert: most serious device problem
Convenience Kit Correction: Cardinal Health Updates Use Instructions for Presource Packs Containing BD Alaris Pump Infusion Sets (opens in a new tab)
Cardinal Health Presource Kits may contain BD Alaris Pump Infusion Sets with Updated Use Instructions.
Also posted about this recall
-
Nov. 9, 2026FDA alert: most serious device problem
Heart Pump Controller Recall: Abiomed Removes Automated Impella Controllers (AIC) (opens in a new tab)
Abiomed is removing certain Impella Controllers with various hardware, firmware, and/or software updates based on a retrospective review of servicing records.
-
Nov. 8, 2026Food contamination
Fresh & Ready Foods LLC Recalls Fresh To You Brand Sausage, Egg & Cheese Biscuit Sandwich due to Possible Health Risk (opens in a new tab)
November 7, 2026, Fresh & Ready Foods LLC of Renton, WA is recalling 2,414 of Fresh To You Sausage, Egg & Cheese Biscuit Sandwiches (4.6 oz) because it has the potential to be contaminated with Listeria monocytogenes, an organism which can...
-
Nov. 6, 2026Company announcementNationwide
Eugia US LLC (f/k/a Auro Medics Pharma LLC) Issues Voluntary Nationwide Recall of Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL (Single Dose Vial) Due to Presence of Particulate Matter (opens in a new tab)
FOR IMMEDIATE RELEASE -November 06,2026, East Windsor, New Jersey, Eugia US LLC (f/k/a Auro Medics Pharma LLC) is voluntarily recalling lot number 3VM26026A of Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL (Single Dose Vial)...
-
Nov. 3, 2026FDA alert: most serious device problem
Early Alert: Compact Medical Removes and Updates Use Instructions for ButterflyBVM Bag-Valve-Mask Resuscitators (opens in a new tab)
Compact Medical removes and updates use instructions for certain ButterflyBVM devices due to development of holes in bellows.
-
Nov. 2, 2026FDA alert: most serious device problem
Early Alert: B. Braun Medical Inc. Removes Streamline Bloodline Set for Dialog+ (opens in a new tab)
The dialyzer connector may not be attached appropriately, resulting in leaking and potential blood loss.
Also posted about this recall
-
Oct. 30, 2026Company announcementNationwide
Vitality Works Inc. Recalls 365 Whole Foods Market Ashwagandha Capsules Sold Nationwide Due to Potential Salmonella Contamination (opens in a new tab)
Vitality Works Inc. of Albuquerque, New Mexico, is recalling one lot (lot number 2025-26227) of 365 Whole Foods Market Standardized + Full Spectrum Blend Ashwagandha Capsules 120 count because it has the potential to be contaminated with...
-
Oct. 30, 2026FDA alert: most serious device problem
Platelet Factor 4 (PF4) Radioimmunoassay Recall: Instrumentation Laboratories Removes HemosIL AcuStar HIT-IgG(PF4-H) (opens in a new tab)
Product performance issue may lead to a false negative result which will delay recognition of heparin-induced thrombocytopenia.
-
Oct. 30, 2026FDA safety notice
Hospital Glucose Meter Correction: Nova Biomedical Updates Use Instructions for StatStrip Glucose Hospital Meter Systems (opens in a new tab)
Update use instructions for StatStrip Glucose Hospital Meter Systems due to the potential for glucose results to be assigned to the incorrect patient.
Also posted about this recall
-
Oct. 29, 2026Food contamination
SLR Food Distribution Inc. Recalls Wise Wife Brand Ground Cinnamon Due to Elevated Lead Levels (opens in a new tab)
SLR Food Distribution Inc. of Hicksville, New York, is voluntarily recalling Wise Wife Brand Ground Cinnamon because it has the potential to be contaminated with elevated levels of lead.
-
Oct. 29, 2026FDA alert: most serious device problem
Early Alert: Medline Removes or Corrects All Medline Brand Beds and Accessories (opens in a new tab)
Medline removes or corrects all brand beds & accessories due to fire, electrical overheating, entrapment & asphyxiation risks. Risk of serious injury or death.
-
Oct. 27, 2026Food contamination
HAIFA SMOKED FISH Recalls Cold Smoked Sprats Due to Potential Health Risk (opens in a new tab)
HAIFA SMOKED FISH of QUEENS NY is recalling approximately 560 lbs. of Cold Smoked Sprats, due to potential contamination with Clostridium botulinum, a bacterium which can cause life-threatening illness. Consumers are warned not to use the...
-
Oct. 24, 2026Company announcement
Tonight We Ride, LLC Issues Voluntary Recall of Ultimate Forza Male Supplement Due to Presence of Undeclared Sildenafil, Tadalafil, and Dapoxetine (opens in a new tab)
October 24, 2026, Tonight We Ride, LLC of Lakeville, Minnesota is voluntarily recalling all lots of Ultimate Forza Male Supplement capsules to the consumer level because it has been found to contain undeclared Sildenafil, Tadalafil, and...
-
Oct. 20, 2026FDA advisory
Update: Import Alert for Certain Olympus Medical Devices Manufactured in Japan - Letter to Health Care Providers (opens in a new tab)
The U.S. Food and Drug Administration (FDA) is alerting health care providers about import alerts for certain medical devices manufactured in Japan by Olympus Medical Systems Corporation (Olympus) and its subsidiaries.
Also posted about this recall
-
Oct. 19, 2026FDA safety notice
Diagnostic Ultrasound System Correction: Philips Ultrasound Issues Updated Use Instructions for Lumify Diagnostic Ultrasound System (opens in a new tab)
A software app or transducer connection problem with the Philips Lumify diagnostic ultrasound system can result in loss of or delays in scanning functionality.
-
Oct. 16, 2026Food contamination
Lidl US Recalls Gelatelli Coffee & Vanilla Gelato Due to Possible Health Risk (opens in a new tab)
ARLINGTON, VA, OCTOBER 16, 2026, Lidl US is recalling one lot of Gelatelli Coffee & Vanilla Gelato with Coffee Sauce & Cookie Pieces 16 FL OZ (1 PT) UPC 4 0564897 22458 Lot: 085261 Best By MAR/26/2028 because it has the potential to be...
-
Oct. 16, 2026Food contamination
Krasnyi Oktyabr Inc. recalls Cold Smoked Salmon (Starfish Seafood) (opens in a new tab)
Potential to be contaminated with Listeria monocytogenes
-
Oct. 15, 2026FDA alert: most serious device problem
Early Alert: Transcatheter Mitral Valve Delivery System Issue from Edwards Lifesciences (opens in a new tab)
Potential balloon burst during inflation can lead to embolism or the need for surgery.
-
Oct. 14, 2026FDA alert: most serious device problem
Infusion Set Recall: BD and CareFusion 303, Inc. Remove BD Alaris Pump Infusion Sets (opens in a new tab)
BD Alaris Pump Infusion Sets are being removed and discontinued; Alaris Pump Module model 8100 has updated performance data
-
Oct. 14, 2026FDA alert: most serious device problem
Convenience Kit Recall: AVID Medical Removes Convenience Kits Affected by BD ChloraPrep Applicator Recall (opens in a new tab)
Avid Medical is removing certain convenience kits affected by the BD ChloraPrep Applicator Recall that may be contaminated with Aspergillus penicillioides.
-
Oct. 13, 2026Company announcementNationwide
Par Health Issues Voluntary Nationwide Recall of Argatroban Injection Due to the Presence of Particulate Matter (opens in a new tab)
FOR IMMEDIATE RELEASE - ROCHESTER, MI- October 13, 2026, Par Health is recalling 22 lots of Argatroban Injection 250 mg/2.5 mL (100 mg/mL) to the hospital/user level. This recall is being conducted due to the presence of particulate...
-
Oct. 13, 2026FDA alert: most serious device problem
Convenience Kit Recall: Medline Removes Convenience Kits Affected by BD ChloraPrep Applicator Recall (opens in a new tab)
Certain Medline convenience kits containing recalled BD ChloraPrep applicators should be removed from use due to potential fungal contamination
Recalls to know about
From the FDA’s recall records, with its newest postings as of Nov. 11 at 1:38 PM CT. Ranked by seriousness, how widely the drug is used, reach and recency
-
Aug. 26, 2026
Drug recall, ongoing
Cyanocobalamin and Trace Elements Injection 4 and 7 more (12 products)
American Regent, sold nationwide
Cyanocobalamin 10,000 mcg/10 mL, Multrys (Trace Elements Injection 4), acetylcysteine 20%, and papaverine 60 mg/2 mL vials were recalled because particles were found. Lots 25082, 25163 and other lots, expiring 9/30/2026 to 8/31/2027, were sold nationwide in the U.S.
FDA reason: Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Class I: could cause serious harm or death
About 1.8 million people in the US are prescribed cyanocobalamin each year.
The FDA record, with lot numbers (opens in a new tab) -
Nov. 4, 2026
Drug recall, ongoing
Valuhealth Extra Strength Pain Relief Acetaminophen
Prodose, sold nationwide
ValuHealth acetaminophen 500 mg, 40-caplet bottles, was recalled because the bottle label says Pain Relief PM instead of acetaminophen. Lot P260252, exp. 4/30/2029, was distributed nationwide in the USA.
FDA reason: Incorrect label placed on product: Outer carton label correctly identifies drug product in bottle as ValuHealth Extra Strength Pain Relief Acetaminophen 500 mg,but inner label on bottle says ValuHealth Extra Strength...
Class III: unlikely to cause harm
In the news: 11 news outlets mentioned acetaminophen in recall stories in the last two weeks.
About 6.5 million people in the US are prescribed acetaminophen each year.
The FDA record, with lot numbers (opens in a new tab) -
Nov. 4, 2026
Drug recall, ongoing
Olmesartan Medoxomil Amlodipine and Hydrochlorothiazide
Macleods Pharma USA, sold nationwide
Olmesartan medoxomil/amlodipine/hydrochlorothiazide tablets, 40 mg/10 mg/12.5mg, in 30-count and 90-count bottles, were recalled because they may not dissolve as required, so the body may absorb less drug than intended. Lots 12251163A and 12251163B, both expiring 05-31-2027, were sold nationwide in the USA.
FDA reason: Failed Dissolution Specifications.
Class II: could cause temporary or reversible harm
In the news: 19 news outlets mentioned olmesartan in recall stories in the last two weeks.
About 18.4 million people in the US are prescribed amlodipine each year.
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Drug recall, ongoing
Amlodipine and Olmesartan Medoxomil
Ascend Laboratories, sold nationwide
Ascend recalled amlodipine/olmesartan 10mg/40mg, 30-tablet bottles because they did not dissolve as required, so the body may absorb less drug than intended. Lot # 25120696, expiring December 31, 2026, was sold nationwide in the United States.
FDA reason: Out of specification due to dissolution.
Class II: could cause temporary or reversible harm
About 18.4 million people in the US are prescribed amlodipine each year.
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Drug recall, ongoing
Levothyroxine Sodium (12 products)
Accord Healthcare, sold nationwide
Accord recalled 25, 50, 125 and 200 mcg levothyroxine tablets in 1000-count bottles, and 200 mcg in 90-count bottles, after tests found less active ingredient than labeled. Lots D2402430, D2402431 and other lots, expiring 08/31/2026 to 01/31/2027, went nationwide.
FDA reason: Subpotent Drug
Class II: could cause temporary or reversible harm
About 19 million people in the US are prescribed levothyroxine each year.
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Drug recall, ongoing
Semaglutide (11 products)
Apollo Care, sold nationwide
Apollo Care recalled semaglutide 7.5 mg, 12.5 mg, 2.25 mg and 2.5 mg sterile multi-dose vials (1.5, 5 or 2.5 mL) after finding foreign particles. Lots AC-017273, AC-017108 and other lots, expiring 8/30/2026 to 5/5/2027, were sold nationwide.
FDA reason: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Class II: could cause temporary or reversible harm
About 8.3 million people in the US are prescribed semaglutide each year.
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Drug recall, ongoing
Levothyroxine Sodium (2 products)
Pfizer, sold nationwide
Levoxyl 175 mcg tablets in 100- and 1000-count bottles were recalled after testing found less active ingredient than the label states. Lots 24W06 and 24W07, expiring 11/30/2026, were sold nationwide and in Puerto Rico.
FDA reason: Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.
Class II: could cause temporary or reversible harm
About 19 million people in the US are prescribed levothyroxine each year.
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Drug recall, ongoing
Brush Buddies and Evo and 3 more (17 products)
Pritam International Private Limited, sold nationwide
Brush Buddies and evo toothpastes, sodium fluoride 0.24% or 0.243%, 3.5- or 4.0-oz tubes, were recalled because they were not made under federal quality rules. Lots LWP240022080309, LWP250035710304C and other lots, exp. 11/30/2026 to 06/04/2028, were sold nationwide.
FDA reason: CGMP Deviations.
Class II: could cause temporary or reversible harm
About 600,000 people in the US are prescribed sodium fluoride each year.
The FDA record, with lot numbers (opens in a new tab)
All recalls, last 90 days
447 recalls, newest first
-
Nov. 10, 2026
Drug recall, ongoing
Metoprolol Tartrate Tablets
Advagen Pharma Limited
Why: Presence of Foreign Tablets/Capsules
Class II: could cause temporary or reversible harm
About 14.6 million people in the US are prescribed metoprolol each year.
The FDA record, with lot numbers (opens in a new tab) -
Nov. 10, 2026
Device recall, ongoing
Physitemp Ret-1 Rectal Probe Model/Catalog Number: Ret-1 and Physitemp Eso-1 for Esophageal and General Purpose Use Ref: Eso-1 . and 8 more (10 items)
Physitemp Instruments
Why: Temperature monitors and associated probes have not been reviewed for safety and effectiveness for intended use.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 10, 2026
Device recall, ongoing
Medline Convenience Kits Containing Bd Urinary Catheter Trays That Include Clini (10 items)
Medline Industries
Why: Convenience kits contain additional product codes and lots of recalled CliniClean Pericare Wipes identified by manufacturer. Wipes may be contaminated with a lubricant used in the manufacturing process. Use of affected...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 10, 2026
Device recall, ongoing
Eleganz Fusion Screw System (2 items)
Dev4
Why: Driver bit included in fusion Screw System may fracture or break during use resulting in intraoperative delay.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 9, 2026
Food recall, ongoing
Country Creek Acres Alfalfa Sprout Seeds Packed in A Clear and Silver Poly Bag
Country Creek
Why: Products contain seed recalled from the supplier and may be contaminated with E. coli and/or Salmonella
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Nov. 9, 2026
Food recall, ongoing
Cold Smoked Sprats
D & M Smoked Fish
Why: May be contaminated with Clostridium botulinum
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Nov. 9, 2026
Food recall, ongoing
Alfalfa Sprouts Hydroponically Grown.
Francisco Family Foods
Why: Potential E. coli and Salmonella contamination
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Nov. 9, 2026
Device recall, ongoing
Ams
Boston Scientific
Why: Potential for the Rear Tip Extender (RTE) size contained within the package to differ from the size identified on the product labeling. Certain packages labeled as containing a 0.5 cm RTE may contain a 1.5 cm RTE.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 9, 2026
Device recall, ongoing
Straumann Blc Implants and Straumann Healing Abutments (2 items)
Straumann USA
Why: Potential exposure to contamination, possibly compromising the sterility and cleanliness.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 9, 2026
Drug recall, ongoing
Umary Acido Hialuronico
Ibeautistore.Com
Why: Marketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone, Diclofenac and Omeprazole.
Not Yet Classified
The FDA record, with lot numbers (opens in a new tab) -
Nov. 7, 2026
Device recall, ongoing
Cardinal Health Presource Pbds Kits (2 items)
Cardinal Health 200
Why: Notification of performance disclosures of kit component.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Nov. 6, 2026
Drug recall, ongoing
Lisdexamfetamine Dimesylate Capsules
Sun Pharmaceutical Industries
Why: Failed Dissolution Specifications
Class II: could cause temporary or reversible harm
About 1.6 million people in the US are prescribed lisdexamfetamine each year.
The FDA record, with lot numbers (opens in a new tab) -
Nov. 6, 2026
Device recall, ongoing
Vesco Q Enteral Feeding Pump and Vesco Q and 1 more (7 items)
Vesco Medical
Why: The feeding pump may deliver enteral fluids outside its labeled accuracy specification of +/-5%. This inaccuracy can result in over-delivery or under-delivery of enteral fluids relative to the prescribed dose, if proper...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 6, 2026
Drug recall, ongoing
Orl Organic Oral Care Bubblegum Kids Natural Toothpaste and Orl Organic Oral Care Cinnamint Toothpaste and 4 more (6 products)
Orl Labs
Why: Cross-contamination: The firm was notified by the FDA of sampling results which found the presence of progesterone, estradiol, or dehydroepiandrosterone (DHEA)
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 6, 2026
Food recall, ongoing
Raw Milk Cheddar Cheese Packed in Vacuum Sealed Clear Plastic with A White
Family Farmstead Dairy
Why: Potential contamination with E. coli (pathogenic non-O157 STEC).
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Nov. 6, 2026
Device recall, ongoing
Gore¿ Viabahn¿ Endoprosthesis with Heparin Bioactive Surface
W L Gore & Associates
Why: Endovascular prosthesis were manufactured on equipment that was not operating with valid parameters and may cause the distal tip to separate.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 6, 2026
Device recall, ongoing
Zynex Medical M-Wave
Altivera Medical
Why: Muscle stimulator may deliver constant electrical impulses to all four electrodes simultaneously, instead of alternating between the electrodes as designed, which may cause muscle fatigue.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 6, 2026
Device recall, ongoing
Philips Allura Xper Systems with Software Releases R8.1.X and R8.2.X Systems and
Philips Medical Systems Nederland B.V.
Why: Software issue that may cause the FlexVision software application to become unresponsive during clinical use.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 6, 2026
Device recall, ongoing
Acuson Orgin Ultrasound Imaging System Ref: and Acuson Orgin Ice Ultrasound Imaging System Ref: and 2 more (4 items)
Siemens Medical Solutions USA
Why: A software issue identified in the ultrasound system may result in the unintended activation of the Color Doppler setting, which has not received FDA clearance. This unintended activation could cause the system to crash...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 6, 2026
Device recall, ongoing
Tcd Electrodes
Boston Scientific Neuromodulation
Why: Radiofrequency probes may have small cut marks on the Tyvek side of the sterile pouch, and if the sterile barrier is compromised and devices are used, this could cause microbial or other foreign material contamination...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 6, 2026
Device recall, ongoing
Carelink Smartsync Device Manager App and Programmer and 1 more (3 items)
Medtronic
Why: Bluetooth disconnections may occur between the device manager software and its associated accessories. Bluetooth disconnections during a SmartSync patient session may lead to harm due to undesirable or incomplete...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 6, 2026
Device recall, ongoing
Artis Icono Biplane. Model Number: and Artis Icono Ceiling. Model Number: and 2 more (4 items)
Siemens Medical Solutions USA
Why: Potential that the system may not execute movement control commands as intended and may display the following message to the user, "Limited stand/table movement, SC."
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 6, 2026
Device recall, ongoing
Atellica Ch Hdl Cholesterol and Atellica Ch Total Protein_2 (2 items)
Siemens Healthcare Diagnostics
Why: Reagent probe carryover on the Atellica CH and Atellica CI Analyzers may cause falsely elevated Hemoglobin A1c (A1c_E/A1c_H) results due to HDLC carryover (biases of 9 29% in NGSP units), and falsely depressed Direct...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 6, 2026
Device recall, ongoing
Ocs Heart Perfusion Set Model/Catalog Number: and Ocs Liver Perfusion Set Model/Catalog Number: and 1 more (3 items)
Transmedics
Why: The Perfusion Module may have an unprogrammed Front End Board (FEB) which will not allow the system to proceed beyond the initial startup process. The OCS system will display an error message saying Unsupported...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 6, 2026
Device recall, ongoing
Ocs Liver Perfusion Set Model/Catalog Number:
Transmedics
Why: Incorrectly assembled device sets with incorrect accessories.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 6, 2026
Device recall, ongoing
Ocs Heart System Ocs Heart Perfusion Set Model/Catalog Number: and Ocs Liver System Ocs Liver Perfusion Set Model/Catalog Number: and 1 more (3 items)
Transmedics
Why: Incorrectly assembled device kits that include incorrect components.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 6, 2026
Device recall, ongoing
Sheehy Ventilation Tube and Bobbin Ventilation Tube (2 items)
Medtronic Xomed
Why: Ventilation tubes, that provide a passageway for movement of air between the auditory canal and the middle ear, were not subjected to the required sterilization process, which after implantation could cause infection...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 6, 2026
Device recall, ongoing
Ocs Liver System for Organ Transport Ocs Liver Perfusion Set Model/Catalog Numbe and Ocs Liver System for Organ Transport Ocs Liver Solution Infusion Set Model/Catal and 1 more (3 items)
Transmedics
Why: Faulty Solution Delivery System (SDS) Cassettes within the device set were assembled with syringes that were manufactured with an atypical lubricant, which results in sub-par performance and has the potential to cause...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 5, 2026
Device recall, ongoing
Halyard Arthroscopy Pack. Model/Catalog Number: Samm014-21.
Avid Medical
Why: Shelf label of kit is mislabeled as "Extremity" instead of "Arthroscopy Pack."
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 5, 2026
Device recall, ongoing
Liaison Plex Gram-Negative Blood Culture Assay Catalog No.
Luminex
Why: Instructions for Use updated to include explicit guidance that repeat testing is recommended whenever a positive family-level only result is obtained. Issue may contribute to incorrect or delayed diagnosis of...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 5, 2026
Food recall, ongoing
Wise Wife Ground Cinnamon in Plastic Container with Black Screw Top Cap
Slr Food Distribution
Why: Product contains elevated levels of lead
Not Yet Classified
The FDA record, with lot numbers (opens in a new tab) -
Nov. 5, 2026
Food recall, ongoing
365 Whole Foods Market Standardized + Full Spectrum Blend Ashwagandha Capsules
Vitality Works
Why: Possible Salmonella contamination.
Not Yet Classified
The FDA record, with lot numbers (opens in a new tab) -
Nov. 4, 2026
Drug recall, ongoing
Olmesartan Medoxomil Amlodipine and Hydrochlorothiazide
Macleods Pharma USA, sold nationwide
Olmesartan medoxomil/amlodipine/hydrochlorothiazide tablets, 40 mg/10 mg/12.5mg, in 30-count and 90-count bottles, were recalled because they may not dissolve as required, so the body may absorb less drug than intended. Lots 12251163A and 12251163B, both expiring 05-31-2027, were sold nationwide in the USA.
FDA reason: Failed Dissolution Specifications.
Class II: could cause temporary or reversible harm
In the news: 19 news outlets mentioned olmesartan in recall stories in the last two weeks.
About 18.4 million people in the US are prescribed amlodipine each year.
The FDA record, with lot numbers (opens in a new tab) -
Nov. 4, 2026
Drug recall, ongoing
Valuhealth Extra Strength Pain Relief Acetaminophen
Prodose, sold nationwide
ValuHealth acetaminophen 500 mg, 40-caplet bottles, was recalled because the bottle label says Pain Relief PM instead of acetaminophen. Lot P260252, exp. 4/30/2029, was distributed nationwide in the USA.
FDA reason: Incorrect label placed on product: Outer carton label correctly identifies drug product in bottle as ValuHealth Extra Strength Pain Relief Acetaminophen 500 mg,but inner label on bottle says ValuHealth Extra Strength...
Class III: unlikely to cause harm
In the news: 11 news outlets mentioned acetaminophen in recall stories in the last two weeks.
About 6.5 million people in the US are prescribed acetaminophen each year.
The FDA record, with lot numbers (opens in a new tab) -
Nov. 4, 2026
Drug recall, ongoing
Atorvastatin Calcium
Msn Laboratories Private Limited (Formulations Division, Unit-Ii), sold nationwide
Why: Presence of Foreign Tablets/Capsules
Class II: could cause temporary or reversible harm
About 29.7 million people in the US are prescribed atorvastatin each year.
The FDA record, with lot numbers (opens in a new tab) -
Nov. 4, 2026
Drug recall, ongoing
Formoterol Fumarate Dihydrate
the Ritedose, sold nationwide
Why: Failed Impurities/Degradation Specification
Class II: could cause temporary or reversible harm
About 1.9 million people in the US are prescribed formoterol each year.
The FDA record, with lot numbers (opens in a new tab) -
Nov. 4, 2026
Drug recall, ongoing
Wechem Hand Guard8/1000ml Bag and Lynx and 15 more (19 products)
Abc Compounding Co., sold nationwide
Why: CGMP Deviations
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 4, 2026
Drug recall, ongoing
Metoclopramide
Safecor Health, sold nationwide
Why: Manufacturer is recalling batches due to co-mingled tablet.
Class II: could cause temporary or reversible harm
About 590,000 people in the US are prescribed metoclopramide each year.
The FDA record, with lot numbers (opens in a new tab) -
Nov. 4, 2026
Drug recall, ongoing
Lidocaine Ointment USP
Direct Rx, sold nationwide
Why: Subpotent Drug
Class II: could cause temporary or reversible harm
About 610,000 people in the US are prescribed lidocaine each year.
The FDA record, with lot numbers (opens in a new tab) -
Nov. 4, 2026
Device recall, ongoing
Automated Impella Controller and Impella Optical Controller and 1 more (3 items)
Abiomed, sold nationwide
Why: Retrospective review of servicing records identified AIC units requiring various hardware, firmware, and/or software update(s): 1. RFID firmware issue that may result in failure of the AIC to recognize the purge...
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Nov. 4, 2026
Drug recall, ongoing
Electric Medicated Balm Ultra Strength
Fei Fah Medical Manufacturing Pte., sold nationwide
Why: CGMP Deviations
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 4, 2026
Drug recall, ongoing
Carboxymethylcellulose Sodium
Huons Co., sold nationwide
Why: Failed Impurities/Degradation Specification; detection of polyethylene (PE)-related oligomers
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 4, 2026
Drug recall, ongoing
Lidocaine
Trifluent Pharma
Why: Labeling: Incorrect or Missing Lot and/or Exp Date. Incorrect expiration date printed on the label.
Not Yet Classified
About 610,000 people in the US are prescribed lidocaine each year.
The FDA record, with lot numbers (opens in a new tab) -
Nov. 4, 2026
Device recall, ongoing
Philips Azurion and Philips Azurion S. Model Number: (9 items)
Philips Medical Systems Nederland B.V., sold nationwide
Why: Solid-State Drives (SSDs) that are not specified in the Medical Device File may have been installed in various PCs. These SSDs may have different performance characteristics, which may include reduced reliability over...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 4, 2026
Device recall, ongoing
Pentax Medical Ultrasound Endoscope. Model Numbers. Eg-3870utk and Pentax Medical Water Bottle Assembly. Model Number. Os-H5. and 3 more (5 items)
Pentax of America, sold nationwide
Why: Warnings added to the IFU for ultrasound endoscopes and water bottle assembly to ensure there is deaerated sterile water in the assembly prior to and during the procedure.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 4, 2026
Drug recall, ongoing
Vecuronium Bromide (2 products)
Meitheal Pharmaceuticals, sold nationwide
Why: Labeling: Label Lacks Warning or Rx Legend
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 4, 2026
Drug recall, ongoing
Theophylline Extended-Release Tablets (2 products)
Brandywine Pharmaceuticals, sold nationwide
Why: CGMP Deviations: interruption in the ongoing stability testing program conducted at a third-party laboratory
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 4, 2026
Drug recall, ongoing
Phenylephrine HCL Infusion and Oxytocin (2 products)
Eagle Pharma Outsourcing, sold nationwide
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 4, 2026
Drug recall, ongoing
Abiraterone Acetate
Glenmark Pharmaceuticals Inc., USA, sold nationwide
Why: Labeling: Not Elsewhere Classified
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 4, 2026
Device recall, ongoing
Omniasecure Model
Medtronic, sold nationwide
Why: Affected leads require additional engineering evaluation due to complaints regarding difficulty in achieving fixation during implantation. Potential harm of tissue trauma due to implant difficulty.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 4, 2026
Device recall, ongoing
Alphenix Interventional Angiography System Ref: Infx-8000f and Alphenix Interventional Angiography System Ref: Infx-8000c and 1 more (3 items)
Canon Medical System, USA, sold nationwide
Why: Due to software issue, X-ray interventional system may experience internal error if F-Store or imagine acquisition is performed while clinical analysis function is use.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 4, 2026
Device recall, ongoing
Carelink Smartsync Programmer and Carelink Smartsync and 1 more (3 items)
Medtronic
Why: Software problem has the potential for an inaccurate displayed longevity estimate.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 4, 2026
Device recall, ongoing
Nalu Td2 Therapy Disc with Firmware
Boston Scientific Neuromodulation, sold nationwide
Why: Therapy Disc (TD) that powers and sends stimulation signals to an Implantable Pulse Generator (IPG), part of a neurostimulation system, has a firmware issue that causes the TD to attempt to restart, then fail, leading...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 4, 2026
Device recall, ongoing
Emag System Model/Catalog Number:
Biomerieux Sa, sold nationwide
Why: Delayed or no result when analyzing clinical samples with EMAG system (ref: 418591/418591U) due to a randomly occurring software error, Error 10003 Heater timeout after updating to recent firmware SP4 Patch 2
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 4, 2026
Device recall, ongoing
Model Number:
Philips North America, sold nationwide
Why: Potential for the device to fail immediately after an exposure, causing the system to remain stationary.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 4, 2026
Device recall, ongoing
Precision Pointer Electromagnetic
Stryker Leibinger Gmbh & Co. Kg, sold nationwide
Why: Device may fracture during use at the laser welded joint on the pointer tube. If this happens, loose parts may fall out of the product while the device is inside the patient.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 4, 2026
Device recall, ongoing
Carevo
Arjohuntleigh Polska Sp. Z.O.O., sold nationwide
Why: The side support of the shower trolley may open unintentionally when the handles are not fully locked and additional force is applied during patient handling. If the side support is not fully locked and an additional...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 4, 2026
Device recall, ongoing
Orthoscan Versa Accessory Cart
Ziehm-Orthoscan, sold nationwide
Why: The accessory cart weldment does not conform to weld dimensional specifications which may result in separation of the monitor arm mounting structure from the cart.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 4, 2026
Device recall, ongoing
Ethilon Nylon Suture
Ethicon
Why: Nylon suture indicated for use in general soft tissue approximation and/or ligation may have needles with distorted curvature, that may break during use, or could cause additional soft tissue or vessel injury, including...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 4, 2026
Biologic recall, ongoing
Apheresis Platelets
American National Red Cross (the), Lewis and Clark Region
Why: Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced, which were exposed to unacceptable storage temperatures, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 4, 2026
Biologic recall, ongoing
Apheresis Platelets
the American National Red Cross
Why: Apheresis Platelets, PAS, Leukocytes Reduced, which were not tested for pH or platelet count, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 4, 2026
Device recall, ongoing
Intelerad Intelepacs Software
Intelerad Medical Systems Incorporated
Why: A cybersecurity vulnerability has been identified in the software that could allow a malicious user to take over an administrator session, delete or modify image or study data, or lock legitimate users out of the...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 4, 2026
Device recall, ongoing
Senographe Pristina (3 items)
Ge Medical Systems
Why: GE HealthCare has become aware of a nonconformance to certain Senographe Pristina VIA systems. Specifically, in cases of 3D+2D manual mode where the acquisition configuration of the anode track/filter combination is...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 3, 2026
Drug recall, ongoing
Cyanocobalamin Injection
American Health Packaging
Why: Presence of particulate matter:American Regent, Inc. notified BluePoint Pharmaceuticals Laboratories regarding potential glass particle contamination (foreign glass fragment) identified in the product batch.
Class II: could cause temporary or reversible harm
About 1.8 million people in the US are prescribed cyanocobalamin each year.
The FDA record, with lot numbers (opens in a new tab) -
Nov. 3, 2026
Drug recall, ongoing
Famotidine Injection
Sagent Pharmaceuticals
Why: Presence of Particulate Matter
Not Yet Classified
About 5.3 million people in the US are prescribed famotidine each year.
The FDA record, with lot numbers (opens in a new tab) -
Nov. 3, 2026
Drug recall, ongoing
Ciprofloxacin Tablets (2 products)
Hikma Pharmaceuticals USA
Why: CGMP Deviations: N-nitroso-ciprofloxacin results above the FDA recommended interim control limit.
Class II: could cause temporary or reversible harm
About 2.5 million people in the US are prescribed ciprofloxacin each year.
The FDA record, with lot numbers (opens in a new tab) -
Nov. 3, 2026
Device recall, ongoing
Generic Name: Perma Sharp Sutures (13 items)
Henry Schein
Why: Products lack 510(k) clearance.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 3, 2026
Device recall, ongoing
Trusystem and Operating Table Column Ts7500 Mobius and 1 more (5 items)
Baxter Healthcare
Why: There is an issue with the main lift mechanism. The main lift may unexpectedly drop from its set position to its lowest position during use. In these cases, the tabletop could not be raised again after the drop...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 3, 2026
Food recall, ongoing
Starfish Seafood Cold Smoked Trio Salmon Halibut Trout and Starfish Seafood Cold Smoked Norwegian Salmon (2 items)
Krasnyi Oktyabr
Why: Contaminated with Listeria monocytogenes
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Nov. 3, 2026
Food recall, ongoing
Gelatelli Naturally Flavored Coffee & Vanilla Gelato with Coffee Sauce & Cookie
Lidl US Trading
Why: Listeria monocytogenes. The firm received positive test result of Listeria monocytogenes in the product.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Nov. 3, 2026
Biologic recall, ongoing
Apheresis Platelets
American Red Cross Biomedical Services Northern New England Region
Why: Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced, lacking documentation of return to acceptable storage temperature, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 3, 2026
Biologic recall, ongoing
Apheresis Platelets
American National Red Cross
Why: Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced, which were not tested for residual white blood cells or red blood cells (RBC) after an RBC spillover during apheresis collection, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 3, 2026
Biologic recall, ongoing
Apheresis Platelets
Impactlife
Why: Apheresis Platelets, Leukocytes Reduced, lacking documentation of acceptable storage temperature and agitation, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 3, 2026
Biologic recall, ongoing
Apheresis Platelets
New York Blood Center Enterprises
Why: Apheresis Platelets, Leukocytes Reduced, Irradiated, which tested repeatedly reactive for anti-HCV, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 3, 2026
Device recall, ongoing
Unity Knee Asc Modular Handle Included in the Corin Unity Asc Instrument System.
Corin Medical
Why: Potential malfunction of the Modular Handles where the locking mechanism may fail. Any mating instruments already engaged to the handle will not be able to be disengaged, and the handle will be unable to fitted securely...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 3, 2026
Device recall, ongoing
Halyard Minor Pack. Model/Catalog Number: Vasf105-08.
Avid Medical
Why: Potential for open seals on header bags, compromising sterility.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 3, 2026
Device recall, ongoing
Trusystem and Mobile Column Trusystem (2 items)
Baxter Healthcare
Why: The main lift may unexpectedly drop from its set position to its lowest position during use. The tabletop may not be able to be raised again after the drop occurs. An uncontrolled drop of the surgical table may result...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 3, 2026
Device recall, ongoing
Trinias Opera Smart
Shimadzu Corporation Medical Systems Division
Why: The mounting bolts securing the C-arm drive unit of the X-ray system may not be torqued to specification, potentially compromising structural stability and safe operation.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 3, 2026
Device recall, ongoing
Veritas Reverse Total Shoulder Replacement
Restor3d
Why: (Retroactively reported) Pairing of shoulder implant stem sizes 1 and 2 with the largest glenosphere diameter (40 mm) creates an excessive mechanical loading configuration in which certain polyethylene components lack...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 3, 2026
Device recall, ongoing
Cochlear Nucleus Nexa Cochlear Implant with Contour Advance Electrode Ref P19795
Cochlear Limited
Why: Due to a manufacturing deviation of incomplete electrode welds of cochlear implants and resulting in one or more open circuits
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 3, 2026
Device recall, ongoing
Yeastone Broth
Remel
Why: Affected lot did not meet specifications. Product may report false susceptibility to antifungal agents, specifically within the Azole family.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 2, 2026
Device recall, ongoing
Cardinal Health Presource Pbds Kits (11 items)
Cardinal Health 200
Why: Kits contain infusion sets which were recalled for performance issues.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Nov. 2, 2026
Device recall, ongoing
Generic Name: Edwards Commander M Delivery System Generic Name: Edwards Commande
Edwards Lifesciences
Why: Due to a manufacturing issue which may result in cardiovascular balloon rupturing.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Nov. 2, 2026
Drug recall, ongoing
Delflex Peritoneal Dialysis Solution with (5 products)
Fresenius Medical Care Renal Therapies Group
Why: Lack of Assurance of Sterility:complaints have been received related to potential leaks from small perforations in the print area on the primary bag in the affected lots.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 2, 2026
Biologic recall, ongoing
Red Blood Cells
Versiti Michigan
Why: Red Blood Cells, Leukocytes Reduced, quarantined due to Whole Blood collection using a scale that did not undergo daily quality control, were distributed prior to completion of the investigation.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 2, 2026
Drug recall, ongoing
Tychasis Coats Aloe Lotion and Tychasis Coats Aloe Creme and 1 more (3 products)
Biomed Laboratories
Why: Failed Stability Specifications: OOS stability results included viscosity and appearance results that did not align with the established specifications.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Nov. 2, 2026
Drug recall, ongoing
Glutathione
Premium Health Care
Why: Microbial Contamination of Sterile Products: Out of specifications results were obtained for bacterial endotoxin.
Not Yet Classified
The FDA record, with lot numbers (opens in a new tab) -
Oct. 30, 2026
Drug recall, ongoing
Alpha Lipoic Acid and Ascorbic Acid and 29 more (42 products)
Victory Medical Center Pharmacy
Victory Medical Center Pharmacy recalled alpha lipoic acid 25MG/ML 30ML, ascorbic acid 500MG/ML 50ML, preservative-free ascorbic acid 500MG/ML 50ML and B complex 30ML for lack of processing controls. Lots 2051563, 2022189 and other lots expire 10/19/2026 to 12/1/2026.
FDA reason: Lack of Processing Controls
Class II: could cause temporary or reversible harm
About 300,000 people in the US are prescribed ascorbic acid each year.
The FDA record, with lot numbers (opens in a new tab) -
Oct. 30, 2026
Device recall, ongoing
Tandem Mobi Insulin Pump
Tandem Diabetes Care
Why: Tandem Diabetes Care, Inc. ( Tandem ) has identified that certain Tandem Mobi insulin pumps may generate false-positive occlusion alarms when no actual insulin flow obstruction is present. Investigation determined that...
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Oct. 30, 2026
Device recall, ongoing
Nextseq and Miseq Dx Instrument Ref: Dx-410-1001 / and 3 more (5 items)
Illumina
Why: (Retrospectively reported) Cybersecurity vulnerability identified in communication protocol between the customer-provided infrastructure (network storage, servers, or computers) and in vitro diagnostic devices which may...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 30, 2026
Device recall, ongoing
Hemochron Jr.
Accriva Diagnostics
Why: Microcoagulation test used to evaluate low dose heparin anticoagulation has a mispositioned or absent clot activating reagent, which may result in out-of-range high error code, or erroneously high results, which may...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 30, 2026
Device recall, ongoing
Evos
Smith & Nephew
Why: Incorrect labeling; 3.5MM Partial Articular Lateral Proximal Tibia Plate 6 hole Left 91MM implant labeled and lasered etched as as 3.5MM Lateral Proximal Tibia Plate 6 hole left 91mm implant
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 30, 2026
Device recall, ongoing
Embletta Mpr Pg Multi Parameter Recorder Sleep Monitor
Natus Medical Incorporated
Why: The device may be unable to correctly format its internal memory. When the internal memory cannot be correctly formatted, previously recorded studies may remain on the device and may be updated with incorrect patient...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 30, 2026
Device recall, ongoing
Cryopatch Synergraft
Artivion
Why: A cryopreserved pulmonary human cardiac patch, taken from a 64-year-old human donor, was outside the cardiac tissue donor age specification of newborn to 60 years. The patch was implanted, and due to limitations of...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 30, 2026
Drug recall, ongoing
Fludrocortisone Acetate Tablets
Avkare
Why: Failed Impurities/Degradation Specifications
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 30, 2026
Drug recall, ongoing
Artificial Tears Lubricant Eye Drops
Preferred Pharmaceuticals
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 29, 2026
Biologic recall, ongoing
Pollens - Grasses
Greer Laboratories
Why: Greer Laboratories is requesting a recall for a reported phenol concentration that was recorded at a higher level than the specification limit for lot # 446661 of Standardized Sweet Vernal Grass 100,000 BAU/mL, 5mL...
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 29, 2026
Biologic recall, ongoing
Sterile Diluent for Allergenic Extracts Normal Saline
Greer Laboratories
Why: Greer Laboratories is initiating a voluntary recall of Sterile Diluent for Allergenic Extracts Normal Saline because retention samples from this lot exhibited evidence of glass delamination.
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Drug recall, ongoing
Amlodipine and Olmesartan Medoxomil
Ascend Laboratories, sold nationwide
Ascend recalled amlodipine/olmesartan 10mg/40mg, 30-tablet bottles because they did not dissolve as required, so the body may absorb less drug than intended. Lot # 25120696, expiring December 31, 2026, was sold nationwide in the United States.
FDA reason: Out of specification due to dissolution.
Class II: could cause temporary or reversible harm
About 18.4 million people in the US are prescribed amlodipine each year.
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Drug recall, ongoing
Brush Buddies and Evo and 3 more (17 products)
Pritam International Private Limited, sold nationwide
Brush Buddies and evo toothpastes, sodium fluoride 0.24% or 0.243%, 3.5- or 4.0-oz tubes, were recalled because they were not made under federal quality rules. Lots LWP240022080309, LWP250035710304C and other lots, exp. 11/30/2026 to 06/04/2028, were sold nationwide.
FDA reason: CGMP Deviations.
Class II: could cause temporary or reversible harm
About 600,000 people in the US are prescribed sodium fluoride each year.
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Drug recall, ongoing
Levothyroxine Sodium (2 products)
Pfizer, sold nationwide
Levoxyl 175 mcg tablets in 100- and 1000-count bottles were recalled after testing found less active ingredient than the label states. Lots 24W06 and 24W07, expiring 11/30/2026, were sold nationwide and in Puerto Rico.
FDA reason: Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.
Class II: could cause temporary or reversible harm
About 19 million people in the US are prescribed levothyroxine each year.
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Drug recall, ongoing
Telmisartan and Amlodipine
Viatris, sold nationwide
Why: Superpotent Drug: potential for the Telmisartan content in these lots to exceed specifications
Class III: unlikely to cause harm
In the news: 13 news outlets mentioned amlodipine in recall stories in the last two weeks.
About 18.4 million people in the US are prescribed amlodipine each year.
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Drug recall, ongoing
Ascorbic Acid
Greenwich Rx, sold nationwide
Why: Microbial Contamination of Sterile Products
Class I: could cause serious harm or death
About 300,000 people in the US are prescribed ascorbic acid each year.
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Device recall, ongoing
Vocsn and V+ Pro Emergency and 9 more (12 items)
Ventec Life Systems, sold nationwide
Why: Ventilator's Internal Flow transducer cable connector may disconnect from internal board, potentially resulting in system reboot and interruption of ventilation therapy.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Drug recall, ongoing
Argatroban (2 products)
Par Health USA, sold nationwide
Why: Particulate matter: particulate matter identified as cellulose, polystyrene, polyethylene teraphalate, stainless steel, or stopper material in the product solution.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Drug recall, ongoing
Testosterone Cypionate
Right Value Drug Stores, sold nationwide
Why: Lack of sterility assurance.
Class II: could cause temporary or reversible harm
About 1.7 million people in the US are prescribed testosterone each year.
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Device recall, ongoing
Philips Lumify Diagnostic Ultrasound System
Philips Ultrasound, sold nationwide
Why: Ultrasound system may: 1) Not recognize previous transducer registration, prevent scanning, require re-registration with Wi-Fi/cellular access, which may be unavailable outside of the hospital...
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Device recall, ongoing
Medline Medical Convenience Kits Labeled As: and Medline Medical Convenience Kits Labeled As and 7 more (13 items)
Medline Industries, sold nationwide
Why: Reports of problems with product being difficult to remove from patient and leaving adhesive residue on patient's skin.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Drug recall, ongoing
Heparin Sodium
Shenzhen Techdow Pharmaceutical Co., sold nationwide
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Device recall, ongoing
Direxion Torqueable Microcatheter (41 items)
Boston Scientific Cork, sold nationwide
Why: The product is defective due to insufficient UV curing of the hydrophilic coating which is present on the outer surface of the distal segment of the microcatheters and raised ridges on nitinol sleeves due to laser...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Device recall, ongoing
Lh Lithium Heparin Separator
Greiner Bio-One North America, sold nationwide
Why: Lot B26043FM may include EDTA contamination which introduces potassium while chelating calcium in patient samples, leading to falsely elevated potassium (K+) and falsely decreased calcium (Ca++) results which have the...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Device recall, ongoing
Interstim Percutaneous Extensions Ext and Interstim Surescan Mri Leads (2 items)
Medtronic Neuromodulation, sold nationwide
Why: Wrong lead or percutaneous extension selected. Use of an incompatible lead or percutaneous extension will prevent the system from working as intended and may result in delay of surgery or need for surgical replacement...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Device recall, ongoing
B Braun Safsite Injection Site
B Braun Medical, sold nationwide
Why: Potential for leakage and backflow at the Safsite valve.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Device recall, ongoing
Generic Name: Softmed Breathables Advanced Toric
Coopervision, sold nationwide
Why: The affected products bear an incorrect statement on the carton packaging indicating that the product is "Indicated for Extended Wear". However, this product is intended for daily wear, and the extended-wear statement...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Drug recall, ongoing
Cinacalcet
Strides Pharma, sold nationwide
Why: Failed dissolution specifications
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Device recall, ongoing
Medtronic Biopsy Needle Kit and Medtronic Ndi Passive Spheres Ref: (4 items)
Medtronic Navigation
Why: Sterile Passive spheres and biopsy needle kits contain variation in the reflective material which may affect the ability of the navigation system to detect and track the spheres.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Device recall, ongoing
Pne Lead Implant Kit Ref:
Axonics, sold nationwide
Why: Retroactively Reported: 10mL luer lock syringes included in kit may leak , break or experience other issues that may pose a risk to users.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Drug recall, ongoing
Abiraterone Acetate
Hikma Pharmaceuticals USA, sold nationwide
Why: Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Device recall, ongoing
Ion Torrent Genexus Dx with Software
Life Technologies Holdings Pte, sold nationwide
Why: DNA or RNA sequencing system software has vulnerabilities.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Device recall, ongoing
Generic Name: Minimed Go App Generic Name: Minimed Go App Model/Catalog Number
Medtronic Minimed, sold nationwide
Why: A software defect in which existing users who had previously configured and enabled the long-acting dose reminder feature in version 1.2.0 or earlier experienced failure of the long-acting dose reminder after updating...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Device recall, ongoing
Techno-Path Multichem Ae Unassayed Level and Techno-Path Multichem Ae Unassayed Level (3 items)
Techno-Path Manufacturing, sold nationwide
Why: A routine stability studies have identified a stability drift affecting the Ammonia (NH4+) analyte in specific lots of Multichem AE quality control material. Additional testing confirmed that the labelled shelf-life...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Device recall, ongoing
Rotor Assy-Sw40 and Rotor Assy-Sw41 (2 items)
Beckman Coulter, sold nationwide
Why: Optima XE XPN ultracentrifuge rotors may contain a microstructure defect that can cause rotors to break into two or more pieces (bifurcate) during a centrifugation run, resulting in destruction of samples being...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Device recall, ongoing
Carelink Clinic
Medtronic Minimed, sold nationwide
Why: CareLink Clinic software version 4.4A includes a software defect in the Settings Calculator feature in which the calculation logic fails to use custom values entered by healthcare professionals (HCPs) for Total Daily...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Device recall, ongoing
Think Surgical Square Driver Ref:
Think Surgical, sold nationwide
Why: Robotic system square drive failed to meet design specifications potentially resulting in pin becoming stuck in square driver or the pin wobbling during drilling.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Device recall, ongoing
Philips Smart-Hopping
Philips North America, sold nationwide
Why: Unreliable wireless roaming behavior of Smart-hopping 1.0 wireless clients during transport when connecting to Smart-hopping 2.0 infrastructure, resulting in loss of connectivity to the central monitoring system (PIC...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Device recall, ongoing
Halyard Anterior Hip Pack. Model/Catalog Number: Soah30. and Halyard Anterior Hip Pack. Model/Catalog Number: Soah31. (2 items)
Avid Medical, sold nationwide
Why: A non-sterile component was piggybacked and incorrectly placed outside of the sterile barrier and not subjected to EO sterilization per kit specifications.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Device recall, ongoing
Amplatzer Amulet Left Atrial Appendage Occluder Model Numbers
Abbott, sold nationwide
Why: Changes to Instructions for Use (IFU) for the device regarding risk of Pulmonary Artery Injury (PAI).
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Device recall, ongoing
Generic Name: Restor3d Mtp Implant Generic Name: Mtp Implant Model/Catalog Num
Restor3d, sold nationwide
Why: Implants were found in the field with orange sterilzation indicators which means implants were not exposed to sterilization.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Device recall, ongoing
Xact Mole Marker for Mammography Model/Catalog Number: M15rm
Solstice, sold nationwide
Why: The radiopaque material may detach from the marker. In some cases, artifact was noted and attributed to the detached material.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 28, 2026
Biologic recall, ongoing
Sterile Diluent for Allergenic Extract
Greer Laboratories
Why: Greer Laboratories dba Stallergenes Greer is recalling distributed Sterile Diluent for Allergenic Extracts Normal Saline due to an out of specification (OOS) phenol level (lower than expected) identified during routine...
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 27, 2026
Drug recall, ongoing
Cyanocobalamin Injection
American Regent
Why: Presence of Particulate matter: Identified as glass
Class II: could cause temporary or reversible harm
About 1.8 million people in the US are prescribed cyanocobalamin each year.
The FDA record, with lot numbers (opens in a new tab) -
Oct. 27, 2026
Biologic recall, ongoing
Red Blood Cells
the American National Red Cross
Why: Red Blood Cells, Leukocytes Reduced, collected from a donor who was deferred for accidental blood exposure, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 27, 2026
Biologic recall, ongoing
Pooled Platelets
We Are Blood
Why: Pooled Platelets, Leukocytes Reduced, Irradiated, which were not tested for pH, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 27, 2026
Biologic recall, ongoing
Red Blood Cells
American Red Cross Blood Svcs
Why: Red Blood Cells, Leukocytes Reduced, prepared from whole blood which may have exceeded the acceptable collection volume, were distributed.
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 23, 2026
Food recall, ongoing
Eden Brothers Broccoli Seeds - Calabrese. Sold in Packets
Eden Brothers
Why: Salmonella
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Oct. 23, 2026
Food recall, ongoing
Zestigreens Broccoli Seeds for Sprouting & Microgreens
Fortuna Marketing
Why: Broccoli seeds potentially contaminated with Salmonella
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Oct. 23, 2026
Food recall, ongoing
Miyoko'S Creamery European Style Salted Plant Milk Butter
Prosperity Organic Foods
Why: Product recalled due to yeast, mold, and E. coli.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 22, 2026
Drug recall, ongoing
Amitriptyline Hydrochloride
Avkare
Why: Failed dissolution specifications.
Class II: could cause temporary or reversible harm
About 1.8 million people in the US are prescribed amitriptyline each year.
The FDA record, with lot numbers (opens in a new tab) -
Oct. 22, 2026
Food recall, ongoing
Heirloom Homegrown Green Sprouting Calabrese Broccoli Sprouts Seed. Net Wt.
Eak Distribution
Why: Salmonella.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Oct. 22, 2026
Food recall, ongoing
Gardners Basics Brand Waltham
Gardeners Basics
Why: Salmonella
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Oct. 22, 2026
Biologic recall, ongoing
Ortho Connect
Biomedical Data Solutions Limited
Why: Biomedical Data Solutions is recalling distributed units of the ORTHO CONNECT software due to the software incorrectly rejecting potential discrepant results during the result review process and subsequently exporting...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 22, 2026
Biologic recall, ongoing
Apheresis Platelets
Arup Laboratories
Why: Apheresis Platelets, PAS, Leukocytes Reduced, which were labeled as leukocytes reduced but were not tested to verify residual white blood cell count and for which pH testing was not performed, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 21, 2026
Drug recall, ongoing
Sermorelin and Tirzepatide/Niacinamide (2 products)
Houston Rx, sold nationwide
Why: Lack of process control
Class II: could cause temporary or reversible harm
About 3.5 million people in the US are prescribed tirzepatide each year.
The FDA record, with lot numbers (opens in a new tab) -
Oct. 21, 2026
Drug recall, ongoing
Metoclopramide
Teva Pharmaceuticals USA, sold nationwide
Why: Presence of Foreign Tablets/Capsules
Class II: could cause temporary or reversible harm
About 590,000 people in the US are prescribed metoclopramide each year.
The FDA record, with lot numbers (opens in a new tab) -
Oct. 21, 2026
Drug recall, ongoing
Hydrocortisone Sodium Succinate
Zydus Pharmaceuticals (USA), sold nationwide
Why: Failed Impurities/Degradation Specifications.
Class II: could cause temporary or reversible harm
About 1.3 million people in the US are prescribed hydrocortisone each year.
The FDA record, with lot numbers (opens in a new tab) -
Oct. 21, 2026
Drug recall, ongoing
Metoclopramide
American Health Packaging, sold nationwide
Why: Presence of Foreign Tablets/Capsules
Class II: could cause temporary or reversible harm
About 590,000 people in the US are prescribed metoclopramide each year.
The FDA record, with lot numbers (opens in a new tab) -
Oct. 21, 2026
Device recall, ongoing
Medline Surgical Convenience Kits Labeled As: and Medline Surgical Convenience Kits Labeled As: Open Heart and 3 more (12 items)
Medline Industries, sold nationwide
Why: Medical convenience kits were distributed containing cannula components which do not conform to ISO 80369-7 dimensional requirements and may contribute to leaking or breaking during use.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 21, 2026
Device recall, ongoing
Hemosll Acustar Hit-Lgg (2 items)
Instrumentation Laboratory, sold nationwide
Why: Potential for invalid calibration curve or negative mean bias of up to 47% with patient samples.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Oct. 21, 2026
Device recall, ongoing
Convenience Kits Containing Conmed Airseal Access Ports Advance Laparoscopic and Convenience Kits Containing Conmed Airseal Access Ports Chn Gyn Oncology D and 3 more (6 items)
Medline Industries, sold nationwide
Why: Kits contain CONMED AirSeal Access Ports. The ports were recalled by manufacturer due to potential for erroneous overpressure alerts and system venting during use, which may result in delays or ending procedures.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 21, 2026
Device recall, ongoing
Rapicide Pa Part A High-Level Disinfectant (3 items)
Steris, sold nationwide
Why: If the vented cap becomes blocked, gas may accumulate and the bottle may swell due to increased internal pressure. In some cases, excess vapor or liquid chemistry may escape from the bottle when the cap is twisted...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 21, 2026
Device recall, ongoing
Bd Phoenix Panel Nmic-312. Catalog Number: and Bd Phoenix Panel Nmic-306. Catalog Number: (2 items)
Becton Dickinson &, sold nationwide
Why: Potential for quality control failures with Klebsiella pneumoniae ATCC BAA-1705 when using the CPO Ambler classification feature.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 21, 2026
Device recall, ongoing
Vinyl Instrument Guards
Healthmark Industries Co., sold nationwide
Why: Labeling not compliant with 21 CFR 801 and steam sterilization IFU has been updated.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 21, 2026
Device recall, ongoing
Power F2 Powered Fastening System
Ferno-Washington, sold nationwide
Why: Firmware issue may result in intermittent loss or degradation of powered functionality when paired with compatible stretcher. The issue may lead to the system not operating in powered mode, or exhibiting reduced powered...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 21, 2026
Device recall, ongoing
Grafton" Dbm and Grafton Plus" Dbm Contain Demineralized Human Bone Tissue Combi and Grafton" Dbm and Grafton Plus" Dbm Contain Demineralized Human Bone Tissue Comb (2 items)
Medtronic Sofamor Danek USA, sold nationwide
Why: Medtronic identified through donor record review that the donor for Medtronic batch A62881 did not meet all Medtronic donor eligibility requirements related to the presence of microbial organisms. While the batch passed...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 21, 2026
Device recall, ongoing
Medline Convenience Kit Labeled As: Foot Ankle. Medline Kit Sku Dynj65395a
Medline Industries, sold nationwide
Why: Discrepancy in the shelf-life of a component
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 21, 2026
Device recall, ongoing
Likorall Overhead Lifts Product Code:
Baxter Healthcare, sold nationwide
Why: Potential issue involving motor shaft breakage combined with reduced performance of the Single Fault Safety (SFS) system may lead to instances where the lift strap lowers more quickly than expected during use. Patients...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 21, 2026
Device recall, ongoing
Dxu and Iq200 Sprint (2 items)
Beckman Coulter, sold nationwide
Why: The rinse-line check valve has a shorter service lifespan than originally expected and requires annual replacement to prevent lamina fluid leakage; however, the check valve replacement was excluded from the annual...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 21, 2026
Device recall, ongoing
Generic Name: Biofire¿ Joint Infection and Generic Name: Filmarray¿ Pneumonia Panel Plus Generic Name: Filmarray¿ Pneumonia and 1 more (3 items)
Biofire Diagnostics, sold nationwide
Why: Due to potential contaiminated of spefic lots of pneumonia and joint infection panels that could result in false positive results
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 21, 2026
Device recall, ongoing
Intelepacs
Intelerad Medical Systems Incorporated, sold nationwide
Why: Following a Chromium-based web-browser, report and displayed images may not match.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 21, 2026
Device recall, ongoing
the Abl90 Flex and Abl90 Flex Plus Analyzers Are Intended for Use By Trained Tec
Radiometer Medical Aps, sold nationwide
Why: In vitro diagnostic analyzer had a risk of potentially inaccurate results requiring changes to instructions for use and: 1) Sample types, including whole blood samples no longer suitable for testing FHbF and ctBil, 2)...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 21, 2026
Device recall, ongoing
Iomax Cortical Module
Cadwell Industries, sold nationwide
Why: Stimulator device contains a defective printed circuit board assembly (PCBA) that may cause the device to unintentionally deliver electrical stimulation to the patient, or allow an unintended electrical current to reach...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 21, 2026
Device recall, ongoing
Ifuse Torq Implant System Model/Catalog Number:
Si-Bone, sold nationwide
Why: The pelvic fixation screws failed to meet acceptance criteria for tube packaging seal integrity testing; therefore, sterility assurance cannot be ensured.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 21, 2026
Device recall, ongoing
Ref: P65 St862 Colag Screw
In2bones USA, sold nationwide
Why: Due to labeling error, bone screws specified as fully threaded, are actually partially threaded screws.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 21, 2026
Device recall, ongoing
Jenavalve Trilogy Delivery Catheter (3 items)
Jenavalve Technology, sold nationwide
Why: Delivery Catheter may have sleeve liner separation that results in difficulty or inability to deploy heart valve device.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 21, 2026
Device recall, ongoing
Mas Omni Immune Pro Liquid Assayed Integrated Immunoassay Control
Microgenics, sold nationwide
Why: Vial-to-vial variability in MAS¿ Omni"IMMUNE PRO Liquid Assayed Integrated Immunoassay Control, Level 1, Lot OPRO29061A results in low Parathyroid Hormone (PTH) recovery, which may lead to a delay in reporting patient...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 21, 2026
Device recall, ongoing
Generic Name: Gore Viabil Short Wire Biliary Endoprosthesis
W L Gore & Associates, sold nationwide
Why: The potential for the devices to be mislabeled with the incorrect length.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 21, 2026
Device recall, ongoing
Perma-Hand Silk Black Braided Sterile Nonabsorbable Surgical Suture
Ethicon, sold nationwide
Why: Silk sutures, indicated for use in cardiovascular, ophthalmic and neurological procedures, packaged with alcohol-based fluid, not part of product design, that if discovered prior to use may cause surgical delay. If...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 21, 2026
Device recall, ongoing
Forward Gunshot Wound Kit
Integrated Medcraft, sold nationwide
Why: Subrecall of a kitted device from SafeGuard Medical due to internal testing identified an issue affecting the device's sterile pad, potentially causing the sterile pad to degrade over time. The degradation may cause...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 21, 2026
Device recall, ongoing
Curaplex Capnography Etco2/O2 Oral/Nasal Cannula Multipack
Sarnova Hc, sold nationwide
Why: Affected kits were assembled with pediatric nasal cannula instead of the intended adult nasal cannula.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 21, 2026
Device recall, ongoing
Naviflex Lw Pusher
Boston Scientific, sold nationwide
Why: Device was incorrectly manufactured with a guidewire exit port (referred to in the IFU as the RX port), which is not a design feature associated with this device configuration.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 21, 2026
Device recall, ongoing
Neurostar Advanced Therapy System. Contains the Neurostar Hp Coil Assembly Part
Neuronetics, sold nationwide
Why: Cables are not in conformance with the product specifications required in the production of the HP Coil Assembly.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 21, 2026
Food recall, ongoing
Wild West Seeds Broccoli Seeds Green Sprouting Calabrese Lot #4105. Net Wt.
Wild West Seed
Why: Salmonella
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Oct. 21, 2026
Device recall, ongoing
Ts Universal Baseplate Finishing Tray and Triathlon Hinge Femoral Prep Tray. Catalog Number: and 2 more (4 items)
Howmedica Osteonics
Why: Reprocessing instructions provided in LSTPI-B specify a sterilization dry time of 30 minutes for the trays sterilized in blue wrap. When blue wrap is used, the 30-minute dry time may lead to a small amount of residual...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 21, 2026
Device recall, ongoing
Williams Cystoscopic Injection Needles
Cook Incorporated
Why: The female Luer lock adapter component in the affected device lots may not have been correctly seated due to misalignment and inadequate torquing during manufacturing. Potential events that may occur as a result of this...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 21, 2026
Device recall, ongoing
Scout Md
Merit Medical Systems
Why: The implantable clip may experience difficulties deploying, which could prevent the reflector from functioning as intended during use.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 21, 2026
Device recall, ongoing
Leadcare Ii Blood Lead Test Kit. Model/Catalog Number:
Magellan Diagnostics, sold nationwide
Why: In kit sub-lot 2530M-01 the date of expiration printed on the outer labeling may indicate the wrong expiration date of July 22, 2026 while the correct expiration date is July 13, 2026. If used the system will display an...
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 14, 2026
Drug recall, ongoing
Quad-Mix and Tirzepatide/Cyanocobalamin and 5 more (16 products)
Carolina Infusion, sold nationwide
Why: Lack of Assurance of Sterility: Related to processing equipment used in compounded product.
Class II: could cause temporary or reversible harm
About 3.5 million people in the US are prescribed tirzepatide each year.
The FDA record, with lot numbers (opens in a new tab) -
Oct. 14, 2026
Drug recall, ongoing
Tirzepatide Injection and Apothecary Nad+ Injection (2 products)
Apothecary Pharma, sold nationwide
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible harm
About 3.5 million people in the US are prescribed tirzepatide each year.
The FDA record, with lot numbers (opens in a new tab) -
Oct. 14, 2026
Drug recall, ongoing
Glycerin, Hypromellose, Polyethylene Glycol 400 and Dextran 70, Polyethylene Glycol 400, Povidone, Tetrahydrozoline HCL and 5 more (8 products)
K.C. Pharmaceuticals, sold nationwide
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 14, 2026
Drug recall, ongoing
Lidocaine Ointment USP
Preferred Pharmaceuticals, sold nationwide
Why: Failed Content Uniformity Specifications
Class II: could cause temporary or reversible harm
About 610,000 people in the US are prescribed lidocaine each year.
The FDA record, with lot numbers (opens in a new tab) -
Oct. 14, 2026
Drug recall, ongoing
Ascorbic Acid:
Centric Compounding, sold nationwide
Why: Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.
Not Yet Classified
About 300,000 people in the US are prescribed ascorbic acid each year.
The FDA record, with lot numbers (opens in a new tab) -
Oct. 14, 2026
Device recall, ongoing
Sediplast
Polymedco, Inc. / Polymedco Cancer Diagnostic Products, sold nationwide
Why: During use of an affected tube, the operator may encounter increased resistance when inserting the pipette. The resulting pressure buildup may cause the tube cap to detach or be forcibly ejected, potentially resulting...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 14, 2026
Drug recall, ongoing
Tretinoin (3 products)
Sun Pharmaceutical Industries, sold nationwide
Why: Failed Impurities/Degradation Specifications
Class III: unlikely to cause harm
About 1.7 million people in the US are prescribed tretinoin each year.
The FDA record, with lot numbers (opens in a new tab) -
Oct. 14, 2026
Device recall, ongoing
Verify Biological Steam Test Pack Model/Catalog Number: S3065 and Verify Biological/Integrator Challenge Pack Model/Catalog Number: Lcb006 and 4 more (6 items)
Steris, sold nationwide
Why: Geobacillus stearothermophilus spore population in affected products may fall below minimum shelf life specification. When used to monitor steam sterilization cycles, the potential hazard is that the biological...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 14, 2026
Device recall, ongoing
Battle Bandage
Safeguard US Operating, sold nationwide
Why: Compression bandage may be degraded, which may cause unwanted foreign material to be introduced inside the wound, which may lead to wound exploration and irrigation, formation of scar tissue, and infection.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 14, 2026
Device recall, ongoing
Robotic Prostatectomy Pack and Adult Heart Tray Shands Jacks and 13 more (15 items)
Avid Medical, sold nationwide
Why: Product may be potentially contaminated with a lubricant used during the manufacturing process.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 14, 2026
Device recall, ongoing
Epm Series Patient Monitor. Patient Monitor Series: Epm and Benevision N1 and N-Series Patient Monitor. Patient Monitor: N12/N15/N17/N19/N22 and 6 more (8 items)
Mindray Ds USA, sold nationwide
Why: Certain monitor operator's manuals contain descriptions that may be insufficient or may require clarification regarding selected physiological alarm functions
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 14, 2026
Drug recall, ongoing
Fosfomycin Tromethamine
Cipla USA, sold nationwide
Why: Failed Impurities/Degradation Specifications
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 14, 2026
Device recall, ongoing
Bard Ep Xt Decapolar Steerable
Stryker Sustainability Solutions, sold nationwide
Why: Diagnostic electrophysiology (EP) catheter may have a breached sterile barrier on the straight seal side of the primary pouch, which if used could lead to particulate embolization, infection, thrombus or ganuloma...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 14, 2026
Device recall, ongoing
Minimed Flex Insulin Pump
Medtronic Minimed, sold nationwide
Why: Some MiniMed Flex insulin pumps were released with missing (i.e., devices with no result or abort test results are presumed to have failed) or failed verification test results in one or more of 9 functional tests. The...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 14, 2026
Device recall, ongoing
Spectral Ct and Spectral Ct
Philips Medical Systems, sold nationwide
Why: Software issues may affect the safety and performance of Spectral CT system(s). The issues may result in image artifacts, wrong slice thickness, or unintended system motion.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 14, 2026
Device recall, ongoing
Rollator (2 items)
Medline Industries, sold nationwide
Why: The front fork stem bolt/wheel assembly may disconnect from the rollator frame tubing. If the front fork stem bolt/wheel assembly disconnects from the rollator frame tubing, the front wheels may become loose or detach...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 14, 2026
Device recall, ongoing
Onkos Surgical Inc. My3d Personalized Pelvic Implant (2 items)
Onkos Surgical, sold nationwide
Why: Personalized pelvic implants inadvertently mixed up and distributed to incorrect customers.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 14, 2026
Device recall, ongoing
Nihon Kohden Cns-6200 Series Central Nurse Station
Nihon Kohden America, sold nationwide
Why: Due to a cybersecurity issue associate with a NULL Pointer Dereferences vulnerabiity. If exploited would potentially cause disruption of the centralized monitoring of multiple beds and the visualization of alarms.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 14, 2026
Device recall, ongoing
Glypto Device
Limitless Cryo Spa, sold nationwide
Why: Lack of 510(k) clearance.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 14, 2026
Device recall, ongoing
Hexavue Focus Integration System
Steris, sold nationwide
Why: A software issue may result in unintended mismatch of patient information on manually printed images. Incorrect patient information appearing on printed images could create a documentation discrepancy or incorrect...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 14, 2026
Device recall, ongoing
Dxc (2 items)
Beckman Coulter, sold nationwide
Why: Beckman Coulter has identified a software issue affecting DxC 500i Clinical Analyzers when testing plasma samples. Following user configuration of a Clinical Chemistry test to use units different from the system...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 14, 2026
Device recall, ongoing
Halyard Laparoscopy Comprehensive Pack Ii Ref:
Gri Medical & Electronic Technology Co., sold nationwide
Why: Laparoscopy packs labeled as "latex free" were found to contain a latex urethral catheter
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 14, 2026
Device recall, ongoing
Alphenix Infx-8000c/B5
Canon Medical System, USA, sold nationwide
Why: Loosening of the bolts securing the longitudinal movement mechanism may cause the tabletop to shift, resulting in [positional/imaging/patient] misalignment and a longitudinal motion error
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 14, 2026
Device recall, ongoing
Beach Chair Surgical Patient Positioner
Quantum Ops, sold nationwide
Why: Due to a manufacturing issue (inadequate weld) for patient head positioning system.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 14, 2026
Device recall, ongoing
Intellijoint Navigation System: Workstation G2 Configured
Intellijoint Surgical, sold nationwide
Why: A navigation system used to aid in selection and positioning of orthopedic implant system components has a workstation that may contain a 15-inch MacBook Pro battery, subject to an Apple battery recall, that may...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 14, 2026
Device recall, ongoing
Sperm Ab Elisa
Drg International, sold nationwide
Why: Potential for false negative patient results.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 14, 2026
Device recall, ongoing
Tuftex¿ Over-the-Wire Embolectomy Catheter
Lemaitre Vascular, sold nationwide
Why: Devices failed in process testing related to the amount of pull force it can sustain prior to the balloon components failing.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 14, 2026
Drug recall, ongoing
Nipocalimab-Aahu
J&J Innovative Medicine
Why: Presence of particulate matter.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 14, 2026
Drug recall, ongoing
Biospectra Tris/Tromethamine
Biospectra
Why: Failed stability specifications
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 14, 2026
Device recall, ongoing
Presource Packs Containing Medtronic Microstream Components: Intubation Kit
Cardinal Health 200
Why: Kits contain Microstream components. Medtronic issued an update to the Instructions for Use of these components due reports of difficulty in disconnecting the adapter from the patient's endotracheal tube to perform a...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 14, 2026
Device recall, ongoing
Generic Name: Kit
Medical Action Industries, Inc. 306
Why: An internal data-entry error caused kit lot 333606 to be labeled with an expiration date of March 31, 2027, instead of February 28, 2027.
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Device recall, ongoing
Medline Basic Homecare Beds and Medlite Homecare Beds and Accessories Mdr1070 and Medline Basic Homecare Beds and Medlite Homecare Beds and Accessories (2 items)
Medline Industries, sold nationwide
Why: Potential fire hazard involving the hand control pendant and associated wiring used with affected beds. Pendant or pendant wiring may overheat, potentially leading to smoking, sparking, melting, burning, or fire....
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Device recall, ongoing
Ventstar Resus Neo. Neonatal.
Draeger, sold nationwide
Why: Potential cracks in the hose, which could lead to leakage or the hose falling off.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Drug recall, ongoing
Estradiol Transdermal
Amneal Pharmaceuticals, sold nationwide
Why: Defective Container; packets were found to be either empty or partially full.
Class II: could cause temporary or reversible harm
About 4.1 million people in the US are prescribed estradiol each year.
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Drug recall, ongoing
Paroxetine Hydrochloride
Apotex, sold nationwide
Why: Failed dissolution specifications.
Class II: could cause temporary or reversible harm
About 1.7 million people in the US are prescribed paroxetine each year.
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Device recall, ongoing
Disposable Tourniquet Cuff and Disposable Bb Tournquet Cuff and 1 more (64 items)
Asp Global, sold nationwide
Why: Due to incorrect expiration date on product manufactured between September 2016 to March 2023. Products are labeled with a 10 year shelf life. The correct validated shelf life is 5 years.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Device recall, ongoing
Intrapulmonary Percussive Ventilation and in-Line Valve and 2 more (7 items)
Percussionaire, sold nationwide
Why: Labeling updated warning not to use Intrapulmonary percussive ventilation (IPV) in conjunction with volatile anesthetic delivery systems because IPV may alter controlled delivery of volatile anesthetic agents, resulting...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Drug recall, ongoing
Benzoyl Peroxide Wash (2 products)
Sv Labs Toronto
Why: Microbial contamination of topical product.
Class II: could cause temporary or reversible harm
About 180,000 people in the US are prescribed benzoyl peroxide each year.
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Drug recall, ongoing
Buprenorphine Hydrochloride
Par Health USA, sold nationwide
Why: Crystallization
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Device recall, ongoing
Performance Pro and Opportunity Flex and 1 more (3 items)
American Nitrile Operations, sold nationwide
Why: Gloves may exhibit defects such as tears, missing fingers, and debris. Use of defective gloves may lead to healthcare personnel and patient exposure to infectious pathogens leading to infection or cross-contamination...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Device recall, ongoing
Fisher Scientific Sure-Vue Serum/Urine Hcg and Fisher Scientific Sure-Vue Urine Hcg and 2 more (4 items)
Alere San Diego, sold nationwide
Why: hCG rapid tests may detect low levels of hCG below the stated assay sensitivity, which may result in false positive result.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Device recall, ongoing
Palacos Mv+G Pro and Palacos Mv Pro and 2 more (4 items)
Heraeus Medical Gmbh (Dental Division), sold nationwide
Why: Potential for monomer liquid leakage.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Device recall, ongoing
Ingenia and Mr and 8 more (12 items)
Philips North America, sold nationwide
Why: When exporting diffusion tensor imaging (DTI) scans from a MR system using the Enhanced MR DICOM format, the exports contain incorrect data (diffusion directions). If the Enhanced MR DICOM export is used in conjunction...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Device recall, ongoing
Quantum Pureflow Standard Heat Exchanger High Flow (2 items)
Spectrum Medical Srl, sold nationwide
Why: Due to blood-to-glycol leak in the heat exchanger.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Device recall, ongoing
Computed Tomography X-Ray System and Positron Emission Tomography and Computed Tomography System (12 items)
Shanghai United Imaging Healthcare Co., sold nationwide
Why: Positron emission tomography and computed tomography x-ray systems have a software problem when Split or Local function is enabled, and multiple RIS exams are merged into a single study, that prevents patient images...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Device recall, ongoing
Atellica Ch Revised C-Reactive Protein
Siemens Healthcare Diagnostics, sold nationwide
Why: The potential for falsely elevated results.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Drug recall, ongoing
Hypromellose Eye Drops 0.7%
Aurolab Trust
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Drug recall, ongoing
Goserelin
Tersera Therapeutics, sold nationwide
Why: Temperature Abuse: Product sat in a non-temperature-controlled FedEx trailer at ambient outdoor conditions for 25.5 hours.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Drug recall, ongoing
Ranolazine
Ajanta Pharma USA, sold nationwide
Why: Failed Dissolution Specifications: below specification
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Device recall, ongoing
Embosphere
Merit Medical Systems, sold nationwide
Why: Microspheres used in embolization of tumors, prostatic arteries, arteriovenous malformations, and blood vessels may have holes in packaging that may affect the sterile barrier, which if used could lead to infection.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Device recall, ongoing
Presource Packs Containing Stryker Strykeflow Ps and Ahto Tube Sets: (4 items)
Cardinal Health 200, sold nationwide
Why: The kits contain tube sets with handpieces that may leak during use. The impacted devices can have the following failures: fluid leakage from the hand piece that can pool on the floor. The impact can range from user...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Device recall, ongoing
Medical Convenience Kits Containing Bd Cliniclean Pericare Wipes Within Bd Urina (3 items)
American Contract Systems, sold nationwide
Why: Kits contain manufacturer-recalled perineal care (pericare) wipes within urinary catheter trays, which may be contaminated with a lubricant used during the manufacturing process. Use of a contaminated wipe may lead to...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Device recall, ongoing
Philips Intrasight Plus Ref:
Volcano, sold nationwide
Why: Software system may associate image data from one patient with another patient's record, potentially resulting in incorrect diagnosis or treatment.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Device recall, ongoing
Mastisol Skin Adhesive
Custom Interventional Pain Management, sold nationwide
Why: Due to manufacturing issues with the liquid skin adhesive containing in surgical convenience trays/kits.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Device recall, ongoing
Penumbra System
Penumbra, sold nationwide
Why: Due to manufacturing issues reperfusion catheters may fracture.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Device recall, ongoing
Novaseq
Illumina, sold nationwide
Why: Retrospectively reported correction for an instrument intended for targeted sequencing of DNA libraries from human genomic DNA used with in vitro diagnostic assays has a server with a security vulnerability.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Device recall, ongoing
Pipeline Flex Embolization Device with Shield Technology Ref Ped2-300-12 Udi-Di
Micro Therapeutics, sold nationwide
Why: Due to incorrect label/product dimensions. Product is supposed to be 3.00 mm in diameter, but unit is packaging was a 2.50 mm in diameter.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Device recall, ongoing
Encor Encompass Breast Biopsy and Tissue Removal System Console
Bard Peripheral Vascular, sold nationwide
Why: Breast biopsy and tissue removal system may experience the following errors: 1) Probe calibration and /or handheld driver failure (code HH01-00020009) , 2) Pressure sensor (code E01-0054000E), which prompts the user to...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Device recall, ongoing
Charlotte Claw Screw
Wright Medical Technology, sold nationwide
Why: Screws, intended for use with polyaxial compression plating system intended for foot osteotomies, was manufactured with missing threads on the screwheads, which if used would prevent a secure rigid engagement with the...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Device recall, ongoing
Olympus Tripp-Lite P580-025
Olympus Corporation of the Americas, sold nationwide
Why: While in the high-power operating mode, a video dropout/blackout may occur when using a particular accessory cable.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Device recall, ongoing
Systems/Units Containing Affected Software/Sql Beckman Coulter Chemistry Analyz
Beckman Coulter Mishima K.K., sold nationwide
Why: Certain AU480 chemistry analyzers, with Windows 10 IoT Enterprise 2021 LTSC PCs, may output the message System Stopped By Fatal Error: DBConnectionError AlarmDB when launching the instrument software, using PC...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Device recall, ongoing
Tandem T:Slim Mobile Application Product Name: T:Slim Mobile Application
Tandem Diabetes Care, sold nationwide
Why: A beta (early-release) version of the iOS application, version 2.13 (TestFlight) had a software issue preventing successful pairing of the t:slim application with Abbott FreeStyle Libre 3 Plus (FSL3P) continuous glucose...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Device recall, ongoing
Noxboxi Nitric Oxide Delivery System. Model Number: Noxbox-I.
Noxbox, sold nationwide
Why: Potential for irregular oxygen readings due to a manufacturing issue affecting certain oxygen sensors.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Device recall, ongoing
Hopkins Telescope
Karl Storz Endoscopy, sold nationwide
Why: Due to incorrect inside packaging label for eyepiece.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Device recall, ongoing
Philips Medical Systems Technologies Ltd. Spectral Ct
Philips North America
Why: The Bolus tracking scan application may crash with a system error message. Bolus Tracker shots may continue to occur even if the contrast threshold is reached. This may result in the patient receiving additional...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Device recall, ongoing
Olympus M3 Gold Autoclavable Foroblique Telescope and Olympus M3 Gold Autoclavable Lateral Telescope (2 items)
Olympus Corporation of the Americas
Why: There are identified discrepancies between the sterilization parameters listed in the Instructions for Use and the sterilization parameters listed in the Japanese package insert.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Oct. 7, 2026
Device recall, ongoing
Heartsine Samaritan Pad
Heartsine Technologies, sold nationwide
Why: Products were distributed without the required Maintenance Supplement, which describes an extra check every 3 months in addition to the monthly check.
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 30, 2026
Device recall, ongoing
Imager Ii Angiographic Catheters M001314001 Imager Ii/5/St/65/038 Bx5
Boston Scientific, sold nationwide
Why: Tip may fracture or detach, leading to device fragments remaining within the patient or migrating through the vasculature. Patient impact may include prolonged procedure or life-threatening embolism.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 30, 2026
Device recall, ongoing
Inca (2 items)
Coopersurgical, sold nationwide
Why: Potential to exhibit a loose connection between the flexible tubing and the nasal cannula, during assembly or while in use, which may result in loss of CPAP pressure, possibly reducing the effectiveness of treatment and...
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 30, 2026
Drug recall, ongoing
Carboxymethylcellulose Sodium and Lubricant Eye Drops-Cameron Pharmaceuticals and 3 more (9 products)
Sterling Pharmaceutical Services, sold nationwide
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 30, 2026
Device recall, ongoing
Halyard IV Start Kit Non-Sterile
Avid Medical, sold nationwide
Why: Convenience kits containing BD ChloraPrep Clear - 1 mL Applicator, which may be contaminated with Aspergillus penicillioides.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 30, 2026
Drug recall, ongoing
Clear Eyes Redness Relief (2 products)
Insight Pharmaceuticals LLC, A Prestige Consumer Healthcare, sold nationwide
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 30, 2026
Drug recall, ongoing
Olanzapine
Macleods Pharmaceuticals Limited, sold nationwide
Why: Failed Impurities/Degradation Specifications:Organic and unspecified impurities above specification.
Class III: unlikely to cause harm
About 670,000 people in the US are prescribed olanzapine each year.
The FDA record, with lot numbers (opens in a new tab) -
Sept. 30, 2026
Device recall, ongoing
Combiset Hemodialysis Blood Tubing Set with Attached Priming Set and Transducer
Fresenius Medical Care Renal Therapies Group, sold nationwide
Why: Communication to recommend reviewing the IFU and ensuring that all treatment preparation and handling steps are performed as instructed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 30, 2026
Device recall, ongoing
Achieva and Ingenia Elition S and Ingenia Elition X and 7 more (12 items)
Philips North America, sold nationwide
Why: A software issue will terminate an examination during the image reconstruction process if the scan parameters are manually adjusted such that reconstruction requirements exceed the available system memory.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 30, 2026
Device recall, ongoing
Cardioroot Woven Collagen Coated Vascular Graft
Intervascular, Sas, sold nationwide
Why: Product failed to meet the specified acceptance criteria for Integral Water Permeability (IWP).
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 30, 2026
Device recall, ongoing
Medline Convenience Kits: (5 items)
Medline Industries, sold nationwide
Why: The kits contain neurological sponges with the potential for unexpected variability of endotoxin levels. Potentially elevated endotoxin levels may present health risks that could require medical intervention, such as...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 30, 2026
Device recall, ongoing
Presource Convenience Kits: (2 items)
Cardinal Health 200, sold nationwide
Why: The kits contain applicators that may exhibit an open or incomplete seal on the packaging of the applicator. Use of a potentially contaminated applicator could result in no patient harm or may lead to localized skin or...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 30, 2026
Device recall, ongoing
Foresight Elite Tissue Oximetry Cable Ref Hemfsm10 Udi-Di Code:
Becton, Dickinson and, sold nationwide
Why: Due to incorrect switching of Channel 1 and 2 on the module and flag labels on the tissue oximetry cables.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 30, 2026
Drug recall, ongoing
Exenatide
Amneal Pharmaceuticals of New York, sold nationwide
Why: Defective Delivery System: Possibility of no medication in the prefilled pen.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 30, 2026
Device recall, ongoing
Olympus Bicoag Hemostasis Probe (4 items)
Olympus Corporation of the Americas, sold nationwide
Why: Potential for detachment of ceramic tip due to manufacturing without the designated amount of adhesive.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 30, 2026
Device recall, ongoing
Medline Convenience Kits Containing Healthmark Instrument Channel Brushes. Sinus and Medline Convenience Kits Containing Healthmark Instrument Channel Brushes. Sin (2 items)
Medline Industries, sold nationwide
Why: Kits contain Healthmark Instrument Channel Brushes, which were recalled by the manufacturer due to the potential for a sharp edge/burr on the end of the brush. Potential hazards associated include cut injury/abrasion...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 30, 2026
Device recall, ongoing
Midmark Iqvitals Zone (4 items)
Midmark, sold nationwide
Why: A performance issue may result in inaccurate blood pressure readings when the Linear Deflation Method is used.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 30, 2026
Device recall, ongoing
Automated Impella Controller
Abiomed, sold nationwide
Why: Retrospective report of issues remedied in 2019 with firmware and software patches: 1. Defects in optical bench (OPB) firmware V2.19, which affected the accuracy and stability of the pressure signal the AIC system...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 30, 2026
Device recall, ongoing
Ngenuity Patient Monitor with Capnography
Criticare Technologies, sold nationwide
Why: Complaint trend where "Checkline Error" alarm presents at device setup, rendering the CO2 monitoring function inoperable. May result in procedure delay.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 30, 2026
Device recall, ongoing
Vitek
Biomerieux
Why: The issue is related to card pouch damage associated with a portion of the lot which was produced on a specific card pouching device, in a specific timeframe, causing a potential risk of false resistant results. False...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 30, 2026
Device recall, ongoing
Spectralis with Flex Module
Heidelberg Engineering Gmbh, sold nationwide
Why: Wheels may come loose when module is being pushed or pulled during movement or transportation, affecting stability of the stand. The stand may tip over as a result. Falling stand may cause impact or crushing injuries...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 30, 2026
Device recall, ongoing
Ref: Hf2postd Homefill Oxygen System Homefill Cylinder D with Cga870 Compatibl and Ref:Hf2pc9 Homefill Oxygen System and 1 more (3 items)
Ventec Life Systems, sold nationwide
Why: Labeling; Oxygen Cylinders do not contain required medical gas labeling
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 30, 2026
Device recall, ongoing
New York Embroidery Studio Trinity Non-Surgical Isolation Gown
New York Embroidery Studio, sold nationwide
Why: Gowns do not consistently meet the minimum liquid-barrier performance required.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 30, 2026
Device recall, ongoing
Ref:
Deroyal Industries, sold nationwide
Why: Myocardial temperature probes contain an incorrect needle. Specifically, an 18mm needle was included instead of a 15mm needle.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 30, 2026
Device recall, ongoing
Pro+ and Pro+ Mrs Surface for Versacare (3 items)
Baxter Healthcare, sold nationwide
Why: There is an error in the product description on the Unique Device Identification (UDI) label. These discrepancies in labeling do not align with the approved product or product specifications and may lead to incorrect...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 30, 2026
Device recall, ongoing
Halyard IV Start Kit Non-Sterile (2 items)
Avid Medical, sold nationwide
Why: Convenience kits containing BD ChloraPrep Clear - 1 mL Applicator, which may exhibit an open or incomplete seal on the packaging of the applicator.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 30, 2026
Device recall, ongoing
Contact Lens
Coopervision, sold nationwide
Why: A small number of lenses within the affected lot are of the incorrect power.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 30, 2026
Device recall, ongoing
Powerled
Maquet Sas, sold nationwide
Why: The potential for the device to detach at the junction between the spring arm and suspension arm and fall causing potential injury.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 30, 2026
Device recall, ongoing
Philips Epiq Elite Diagnostic Ultrasound System Model #
Philips Ultrasound, sold nationwide
Why: Due to software issue with ultrasound system, doppler sample is displayed shallower than its actual measurement location, potentially causing inaccurate blood flow velocity measurements and misdiagnosis.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 30, 2026
Device recall, ongoing
Extended Polyaxial Head
Seaspine Orthopedics, sold nationwide
Why: The proximal thread depth of the spinal device is out of design specification.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 30, 2026
Device recall, ongoing
Volara
Baxter Healthcare, sold nationwide
Why: Contamination within the release test equipment flow path could have affected the accuracy of the nebulizer flow rate. Affected devices returned to firm and testing confirmed devices meet specifications.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 30, 2026
Drug recall, ongoing
Menow Sunscreen Pressed Powder Spf35 Pa+++
Shantou Qiwei Industrial Co.
Why: cGMP Deviations
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 30, 2026
Device recall, ongoing
Olympus Ezdilate Endoscopic Balloon Dilator Wired-Guided
Olympus Corporation of the Americas
Why: Potential for the inflation chart label affixed to the shaft of the device to be incorrect and indicate a balloon diameter of 18, 19, or 20 mm,
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Drug recall, ongoing
Thyroid
Vitruvias Therapeutics, sold nationwide
Why: Superpotent Drug
Class I: could cause serious harm or death
About 1.2 million people in the US are prescribed thyroid each year.
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Drug recall, ongoing
Chlorthalidone
Inventia Healthcare Limited, sold nationwide
Why: Failed Dissolution Specifications
Class II: could cause temporary or reversible harm
About 1.3 million people in the US are prescribed chlorthalidone each year.
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Medline Convenience Kits: (7 items)
Medline Industries, sold nationwide
Why: The kits contain certain lots of sterile applicators which may contain fungal contamination that may occur under certain environmental conditions, allowing the growth of Aspergillus penicillioides. Contamination of skin...
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Statstrip Glucose and B- Ketone Meter. Model No: and Statstrip Glucose Hospital Meter System. Model No: (5 items)
Nova Biomedical, sold nationwide
Why: A software synchronization/timing issue in the barcode scanning and patient data processing component that causes the device to intermittently retain a previously scanned barcode including patient identification (ID)...
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Drug recall, ongoing
Lidocaine
Sun Pharma /Taro, sold nationwide
Why: Failed Content Uniformity Specifications. Out of Specification for Assay during analysis at the 24- month long term stability station, at (25¿C,60%RH).
Class II: could cause temporary or reversible harm
About 610,000 people in the US are prescribed lidocaine each year.
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Automated Impella Controller and Impella Optical Controller with the Below Product Descriptions and Corresponding and 1 more (3 items)
Abiomed, sold nationwide
Why: The potential for purge cassette recognition issues due to the failure of the purge flag component of the purge pressure sensor assembly.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Power-Trialysis Short-Term Straight Dialysis Catheter and Duoglide Short-Term Straight Dialysis Catheter (2 items)
Bard Access Systems
Why: this is a downstream recall of class I recall RES 98777
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Bd Alaris Pump Infusion Sets
Bd Switzerland Sarl
Why: Due to discrepancies in specific attributes in the performance data for infusion sets, which may lead to inappropriate pump performance.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Ref:2b5st Ethicon Endo-Surgery and Ref:B5st Ethicon Endo-Surgery and 4 more (6 items)
Stryker Sustainability Solutions, sold nationwide
Why: Reusable access port system may crack or seperate during use.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Oncology Sets with Drip Chambers and IV Sets with Drip Chambers and 2 more (8 items)
Icu Medical, sold nationwide
Why: Intravascular administration tubing set drip chambers may have black specks potentially due to the plastic molding process leaving discolored polyvinyl chloride (PVC) material within the drip chamber wall that does not...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Scorpio C-Dome Patella 73-2710 73-2910 Scorpio U-Dome Patella 73-311 and Abg I Acetabular Insert Hooded and 10 more (12 items)
Howmedica Osteonics, sold nationwide
Why: Affected devices were manufactured with Ultra High Molecular Weight Polyethylene (UHMWPE) raw material aged in excess of five years. Product has the potential for elevated levels of oxidation, which may result in...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Halyard IV Start Kit Non-Sterile Ref: Kriv26-02
Avid Medical, sold nationwide
Why: Convenience kits contain BD ChloraPrep Clear - 1 mL and FREPP Clear 1.5 mL Applicators which are contaminated with Aspergillus penicillioides
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Haylard and Haylard Univ Imaging Biopsy Trucustom and 2 more (4 items)
Avid Medical
Why: Potential for product quality and sterility issues regarding kits containing Sodium Chloride ampules subject to recall by Spectra Medical.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Hemospray Endoscopic Hemostat
Wilson-Cook Medical, sold nationwide
Why: Due to issue with endoscope adherence and inability to spray powder. Firm will provide an updated Instruction for Use (IFU).
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Percutaneous Insertion Kit (3 items)
Maquet Cardiopulmonary Gmbh, sold nationwide
Why: The packaging may not consistently maintain sterile barrier integrity.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Cadd Yellow Medication Cassette Reservoir with Nrfit Connector US Product Cod
Icu Medical, sold nationwide
Why: Reservoirs may exhibit medication leakage at the joint between luer connector and tubing. Issue could result in delay or interruption of therapy, under delivery of medication, exposure to infectious or toxic agents, or...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Drug recall, ongoing
Fluphenazine HCL Elixir (6 products)
Safecor Health, sold nationwide
Why: Failed Stability Specifications
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Carescape Central Station Cscs V3 Mas800 Desktop Part Number
Ge Medical Systems Information Technologies, sold nationwide
Why: Device may not resume patient monitoring for at least 3 minutes following system restart. Issue can lead to potential delay in recognition of clinically significant events.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Happiest Baby (2 items)
Happiest Baby, sold nationwide
Why: Extra small (ES) and Extra-large (XL) infant sleep sacks have not been reviewed for safety and effectiveness by the FDA.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Centricity Pacs Server V7 and Centricity Pacs V2 and 4 more (6 items)
Ge Healthcare, sold nationwide
Why: Under certain conditions historical imaging data migrated from a legacy system may become incorrectly associated with a different patient. If this occurs, studies or images may be displayed under the wrong patient...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Medrad¿ Stellant Flex Syringe Kit Used with Stellant Flex Ct Injection System
Bayer Medical Care, sold nationwide
Why: Some devices may not have been properly sterilized due to a manufacturing sterilization issue.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Sunmed Tracheal Tube
Well Lead Medical Co., sold nationwide
Why: The 6Fr suction catheter could not pass through the samples smoothly.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Drug recall, ongoing
Dopamine Hydrochloride
Pfizer, sold nationwide
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Aisys Cs2 with Et Control and Et Control and 2 more (4 items)
Datex-Ohmeda, sold nationwide
Why: Anesthesia Delivery Systems containing certain electronic gas mixer assemblies can automatically transition to Alternate O2 control. In Alternate O2 control, the system delivers 100% O2 to the breathing system enabling...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Medline Convenience Kit: Open Heart A Pack
Medline Industries, sold nationwide
Why: The kits contain a Retrograde Coronary Sinus Perfusion (RCSP) cannulae that has the potential for a sterile barrier breach. Sterility of the product cannot be assured. If a compromised pouch seal is not identified prior...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Philips Pic Ix Essentials Ref:867093 and Philips Patient Information Center Ix Ref:866389 (2 items)
Philips North America, sold nationwide
Why: Due to software malfunction, patient information system may freeze and become unresponsive.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Reign Medical Clench Staple System
F & A Foundation, sold nationwide
Why: Bone fixation staple requires a new 510(k); the performance characteristics of this device have not been adequately established.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Captus
Mirion Technologies (Capintec), sold nationwide
Why: Potential for failure of the tension bolt which would allow the spring arm to unexpectedly fall to its lowest position, which is approximately 25 inches (63.5 cm) from the ground.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Pi-Cardia Inc. Shortcut Ref: Z-A-20.003-US
Pi Cardia, sold nationwide
Why: Transfemoral catheter, positing arm may detached due to weld issue.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Boston Scientific Corporation Stonesmart Connect Console Contents:
Boston Scientific, sold nationwide
Why: A subset of power adapters used with the connect console may exhibit higher-than-expected resistance in the electrical grounding path. As a result, the power adaptor may fail electrical safety testing during...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Convenience Kits Myringotomy Pack-Lf Dynj59097a and Convenience Kits Anesthesia Pain Pk League Dynj67925a and 2 more (4 items)
Medline Industries, sold nationwide
Why: Kits may exhibit open seals in sterile pouch packaging. Open seal may compromise product sterility. If not detected prior to use, issue may lead to contamination of sterile field or patient infection if product is used.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Noxboxi Nitric Oxide Delivery System.
Noxbox, sold nationwide
Why: Potential for oxygen tubing leaks due to failure of the tubing or tubing connection, which may lead to oxygen desaturation.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Rt Montecarlo
Ptw Freiburg, sold nationwide
Why: When a bolus is included in a treatment plan and sent for secondary dose calculation, the software accounts for it but does not display this clearly, which may lead users to incorrectly omit the bolus during treatment...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Ewo_02512 and Ewo_02513 (2 items)
Embecta Medical Ii, sold nationwide
Why: Retrospectively reported: Pen needles labeled 'For Investigational Use Only' were inadvertently distributed as commercially marketed devices.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Gm Helix Implant
Straumann USA, sold nationwide
Why: There is a discrepancy between the product identification on the packaging and the dimensions of the implant contained inside.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Kinos Axiom Total Ankle System with Axiom Psr
Restor3d, sold nationwide
Why: Ankle implantation systems were packaged with incorrect patient-specific cutting guides, which may result in: delayed surgery, the need to use standard instrumentation, reduced fixation or poor alignment of implants...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Dash Rapid Pcr Instrument
Nuclein, sold nationwide
Why: Due to a software issue
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Blood Culture Collection Venipuncture Kit
Medical Action Industries, Inc. 306, sold nationwide
Why: Blood culture convenience kits contain a component subject to a drug recall that due to an an open or incomplete seal on the packaging of the applicator may compromise the component's sterile barrier and if used may...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Drug recall, ongoing
Epinephrine
American Regent, sold nationwide
Why: Presence of Particulate Matter and Lack of Assurance of Sterility. Particulate matter identified as nylon, cellulosic, acrylic, polyethylene and glass and broken and leaking vials.
Class I: could cause serious harm or death
About 1.1 million people in the US are prescribed epinephrine each year.
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Drug recall, ongoing
Sodium Chloride
B Braun Medical, sold nationwide
Why: Presence of Particulate Matter: particulate matter identified as iron oxide, inorganic material, cellulose cotton fiber or polystyrene
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Device recall, ongoing
Bravo Cf Capsule Delivery Device
Given Imaging, sold nationwide
Why: Capsule may fail to attach to the esophagus or detach from the delivery device. Risks include patient aspiration/inhalation, perforation of esophagus, obstruction of the airway, hemorrhage/blood loss/bleeding...
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Drug recall, ongoing
Dextrose Injection
Baxter Healthcare, sold nationwide
Why: Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Device recall, ongoing
Products That Contain the Pericare Wipes: Surestep" Foley Tray System Add-A-Fol and Products That Contain the Pericare Wipes: Bard¿ Foley Tray with Lubri-Sil¿ All- and 4 more (6 items)
C.R. Bard, sold nationwide
Why: Due to complaints received indicating presence of contamination on the surface of pericare wipes provided with various Foley and Intermittent Catheter Trays.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Device recall, ongoing
Kit: Single Shot Epidural and Kit: Epidural/Pain Tqc (2 items)
Medical Action Industries, Inc. 306
Why: Kits containing Sodium Chloride ampules subject to another recall are recalled due to potentially compromised sterility.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Device recall, ongoing
Medicalyte Liquid Bicarbonate Concentrate Ref: Bc-100 and Bc+201 and Citric Complete Liquid Citric Acid Concentrate Ref: Lc+200-D and 2 more (4 items)
Nipro Renal Soultions USA, sold nationwide
Why: Hemodialysis concentrates contain high endotoxin levels
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Device recall, ongoing
Heartsine Sam
Heartsine Technologies, sold nationwide
Why: Due to a damaged (over stretched) membrane tail that causes an intermittent fault.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Drug recall, ongoing
Fentanyl Citrate
Ourpharma, sold nationwide
Why: Labeling: Not Elsewhere Classified: Complaint received on 08/31/2026 regarding the discrepancy of the IV bag expiry (07/31/2026 and 11/30/2026) and the product expiry (12/09/2026).
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Drug recall, ongoing
Fluphenazine Hydrochloride
Ajanta Pharma USA, sold nationwide
Why: Failed impurities/degradation specifications: (OOS) for Organic Impurities by HPLC (Impurity-A) during testing at the 18 months long term stability. Result: 1.1 percent. Spec: 1.0 percent.
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Device recall, ongoing
Dermav Laser System
Lutronic, sold nationwide
Why: Utilizing higher fluences at 1064nm wavelength with current cryogen parameters may result in a spark/loud noise during treatment, potentially resulting in patient burn.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Device recall, ongoing
Getinge Pvc Thoracic Catheter (3 items)
Atrium Medical, sold nationwide
Why: An Out of Specification result (OOS) related to bacterial endotoxin testing in a single lot of catheters.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Device recall, ongoing
Ams Convenience Kit: Dsaek Pack - Rx
Windstone Medical Packaging, sold nationwide
Why: The convenience kits contain .0.9% Sodium Chloride Injection, USP products in Single Dose freeflex bags, which may contain blue Break-off-Parts (BOPs) that have detached from the infusion port during manipulation.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Device recall, ongoing
Halyard IV Start Kit Non-Sterile Ref: Kriv26-02
Avid Medical, sold nationwide
Why: Convenience kits contain BD ChloraPrep Clear - 1 mL and FREPP Clear 1.5 mL Applicators which lacks sterility assurance due to to wrinkles in the paper lidding which may breach the seal area.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Drug recall, ongoing
Povidone Iodine
Imprimisrx Nj, sold nationwide
Why: Subpotent Drug
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Drug recall, ongoing
Clindamycin Phosphate and Vasopressin and 8 more (17 products)
Baxter Healthcare, sold nationwide
Why: CGMP Deviations
Class II: could cause temporary or reversible harm
About 2.6 million people in the US are prescribed clindamycin each year.
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Drug recall, ongoing
Trazodone Hydrochloride
Teva Pharmaceuticals USA, sold nationwide
Why: Presence of Foreign Tablets/Capsules
Class II: could cause temporary or reversible harm
About 6.4 million people in the US are prescribed trazodone each year.
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Drug recall, ongoing
Ascorbic Acid
Optimal Balance Pharmacy, sold nationwide
Why: Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.
Class I: could cause serious harm or death
About 300,000 people in the US are prescribed ascorbic acid each year.
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Drug recall, ongoing
Chlorhexidine Gluconate
Sage Products, sold nationwide
Why: Cross Contamination with Other Products
Class II: could cause temporary or reversible harm
About 960,000 people in the US are prescribed chlorhexidine each year.
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Drug recall, ongoing
Sodium Chloride
Baxter Healthcare
Why: Presence of particulate matter: Particulates identified as fiberglass
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Drug recall, ongoing
Mycophenolate Mofetil
Mylan Pharmaceuticals, sold nationwide
Why: Failed Dissolution Specifications
Class II: could cause temporary or reversible harm
About 160,000 people in the US are prescribed mycophenolate mofetil each year.
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Drug recall, ongoing
Topiramate) Extended-Release Capsules
Supernus Pharmaceuticals, sold nationwide
Why: Failed dissolution specifications.
Class III: unlikely to cause harm
About 2 million people in the US are prescribed topiramate each year.
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Device recall, ongoing
Medline Convenience Kits: (16 items)
Medline Industries, sold nationwide
Why: The kits contain BD ChloraPrep Clear - 1 mL and FREPP Clear 1.5 mL Applicators which have a potential breach of sterility in the packaging, due to wrinkles in the paper lidding which may extend to the seal area. If the...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Device recall, ongoing
Medline Convenience Kits Containing Bd Chloraprep Clear - (13 items)
Medline Industries, sold nationwide
Why: Convenience kits contain BD ChloraPrep Clear - 1mL Applicators from specific lots that were recalled by the manufacturer because they may have an open or incomplete seal on the applicator packaging. Use of potentially...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Device recall, ongoing
Healon Endocoat Pro
Johnson & Johnson Surgical Vision, sold nationwide
Why: Surgical instructions sent for viscoelastic products used during ophthalmic viscosurgical cataract procedures including in part: If resistance is encountered during insertion, withdraw cannula and reassess the insertion...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Drug recall, ongoing
the One Spf (4 products)
Allies Group, sold nationwide
Why: Subpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Drug recall, ongoing
Prasugrel
Mylan Pharmaceuticals, sold nationwide
Why: Failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Device recall, ongoing
Halyard Medical Convenience Kits Labeled As: and 1) Neuro (3 items)
Avid Medical, sold nationwide
Why: The recall notice was initiated due to a Medicom Urgent Medical Device Recall. Medicom is recalling specific lots of Ritmed¿ Neurological Sponges Non-Sterile Models 55992C to 55998C due to potential for unexpected...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Device recall, ongoing
Presource Packs Containing Cliniclean Pericare Wipes Within Bd Urinary Catheter (12 items)
Cardinal Health 200, sold nationwide
Why: The Urinary Catheter Trays contain CliniClean Pericare Wipes which may potentially be contaminated with a lubricant used during the manufacturing process. If a contaminated wipe is used on a patient, localized skin...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Device recall, ongoing
5008x Hd/Hdf with Twister Blood Tubing Set Part Number and 5008x Standard Hd Pre-Flush Standard Blood Tubing Set Part Number and 2 more (4 items)
Fresenius Medical Care Renal Therapies Group, sold nationwide
Why: Heightened probability of blood leak from the connection between the Arterial Alpha Clip and the main line or pump segment. Leak during treatment may lead to blood loss and hypovolemia.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Device recall, ongoing
Granuflo Dry Acid Concentrate: Product Numbers: and Naturalyte and 1 more (3 items)
Fresenius Medical Care Renal Therapies Group, sold nationwide
Why: Complaints of blue-green discoloration in product
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Device recall, ongoing
Baxter Novum Iq Syringe Pump (2 items)
Baxter Healthcare, sold nationwide
Why: A software issue that may occur during a Volume/Time (VOT) multi-syringe infusion when a syringe reaches empty and is replaced while a Volume To Be Infused (VTBI) remains.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Device recall, ongoing
Discofix Four Way Stopcock
B Braun Medical, sold nationwide
Why: Specific lots of Discofix Stopcock Sets recalled due to an incorrect expiration date printed on the carton shipper label.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Drug recall, ongoing
Doxylamine Succinate and Pyridoxine Hydrochloride
Bionpharma, sold nationwide
Why: Presence of Foreign Tablets/Capsules
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Drug recall, ongoing
Prasugrel
Golden State Medical Supply, sold nationwide
Why: Failed Dissolution Specifications. Notification from the manufacturer that lot is being recalled due to failed dissolution
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Device recall, ongoing
Sta Staclot Protein S
Diagnostica Stago, sold nationwide
Why: A positive drift in QC values within the reagent's stated 4-hour onboard stability period was identified
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Device recall, ongoing
Lux-Dx (3 items)
Boston Scientific, sold nationwide
Why: There is potential for a delay in AF Burden Alert notification affecting the server software which supports the Insertable Cardiac Monitors (ICMs). Delayed notification of an AF Burden Alert may delay clinical...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Device recall, ongoing
Velys Enabling Tech Robotic-Assist Station Ref:
Medos International Sarl, sold nationwide
Why: Software issue within robotic controller which may cause unintended movement of the robotic arm during bone preparation or instrument positioning.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Drug recall, ongoing
Buprenorphine
American Health Packaging, sold nationwide
Why: Labeling: Label Mix-up
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Drug recall, ongoing
Broadway Joe'S Pain Cream (2 products)
Lexia
Why: CGMP Deviations: Potential contamination of raw material
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Device recall, ongoing
Philips Brilliance Ct and Philips Ingenuity Ct Product Codes: Ingenuity Ct Upgrades and 2 more (4 items)
Philips North America
Why: Philips has identified an unintended radiation issue with the Philips IQon, iCT, Ingenuity, and Brilliance CT 64 systems that could affect the performance of the equipment.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Drug recall, ongoing
Elapegademase-Lvlr
Chiesi USA
Why: Failed Stability Specifications: Out of specification stability result for the protein concentration profile.
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Drug recall, ongoing
Levothyroxine Sodium (12 products)
Accord Healthcare, sold nationwide
Accord recalled 25, 50, 125 and 200 mcg levothyroxine tablets in 1000-count bottles, and 200 mcg in 90-count bottles, after tests found less active ingredient than labeled. Lots D2402430, D2402431 and other lots, expiring 08/31/2026 to 01/31/2027, went nationwide.
FDA reason: Subpotent Drug
Class II: could cause temporary or reversible harm
About 19 million people in the US are prescribed levothyroxine each year.
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Drug recall, ongoing
Sodium Chloride, Sodium Lactate, Potassium Chloride, and Calcium Chloride
B Braun Medical, sold nationwide
Why: Presence of Particulate matter.
Class I: could cause serious harm or death
About 4.1 million people in the US are prescribed potassium chloride each year.
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Drug recall, ongoing
Ramipril
Hikma Pharmaceuticals USA, sold nationwide
Why: Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).
Class II: could cause temporary or reversible harm
About 440,000 people in the US are prescribed ramipril each year.
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Drug recall, ongoing
Clobetasol Propionate
Lupin Pharmaceuticals, sold nationwide
Why: Failed content uniformity specifications.
Class II: could cause temporary or reversible harm
About 2.2 million people in the US are prescribed clobetasol each year.
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Drug recall, ongoing
Paroxetine
Apotex, sold nationwide
Why: Failed Dissolution Specifications; product failed to meet 24-month stability testing acceptance criteria
Class II: could cause temporary or reversible harm
About 1.7 million people in the US are prescribed paroxetine each year.
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Drug recall, ongoing
Tocilizumab-Aazg
Fresenius Kabi USA, sold nationwide
Why: Presence of particulate matter:An internal investigation at the firm found the product to contain glass particles.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Drug recall, ongoing
Zicam
Church & Dwight Co., sold nationwide
Why: CGMP Deviations; FDA inspection of the contract manufacturer noted out of limit results for microbiological testing
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Medline Breathing Circuits Labeled As: and Medline Hudson Rci (3 items)
Medline Industries, sold nationwide
Why: Neonatal and infant heated wire breathing circuits may experience sporadic failure. The heated wire connector (pigtail) at the humidifier may exhibit discoloration, melting, smoke, burning odor, or other signs of...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Onli
Hollister Ulc, sold nationwide
Why: Hollister has identified that select lots of the catheters identified in the above table may exhibit a protrusion caused by a manufacturing defect which might lead to genitourinary trauma or bleeding.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Drug recall, ongoing
Acthar Gel
Mallinckrodt Hospital Products, sold nationwide
Why: Presence of particulate matter: glass and stopper piece
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Medline Convenience Kits Labeled As: and Medline Convenience Kits Labeled As: Ltp Cds-Lf and 1 more (11 items)
Medline Industries, sold nationwide
Why: Kits contain a potentially contaminated component which were recalled by the manufacturer
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Halyard Total Joint Model/Catalog Number: Msbm036-03 and Davinci Trucustom Bundle Containing Tray Foley (7 items)
Avid Medical, sold nationwide
Why: Labeling Deficiency: The medical kit labeling fails to identify that the statlock component contains natural rubber latex.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Ort200 and Ort300 (2 items)
Imris Imaging, sold nationwide
Why: The linear actuator and rotational lock mechanism components may experience a mechanical failure that prevents the system from transitioning between locked and unlocked state. This may pose a risk of injury to the...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Powerseal
Olympus Corporation of the Americas, sold nationwide
Why: Potential labeling deficiency in which an outer shelf box is incorrectly labeled as a 37-cm device.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Fresenius Medical Care
Fresenius Medical Care Renal Therapies Group, sold nationwide
Why: Fresenius Medical Care Renal Therapies Group, LLC (FMCRTG) has received complaints regarding flow-, no water-, or temperature-related alarms with the 2008T¿ BlueStar Hemodialysis machines.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Merge Pacs and Merge Orthopacs
Merge Healthcare, sold nationwide
Why: Software issue may cause measurements to be displayed inaccurately.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Alphenix Models Infx-8000c Infx-8000f Infx-8000v This Device Is A Digital
Canon Medical System, USA, sold nationwide
Why: Due to the fixing screws of ceiling movement gear in ceiling suspended arm that are part of the X-ray interventional systems may become loose.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Medline Medical Convenience Kits (4 items)
Medline Industries, sold nationwide
Why: Specific item(s) and lot(s) of Medline convenience kits containing Pilling Wecksorb Neurosponges and Neurosponge Strips are being recalled due to potential out-of-specification levels of endotoxin of the neurosponges.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
American Contract System Convenience Kit and American Contract System Convenience Kits (4 items)
American Contract Systems, sold nationwide
Why: The Convenience Kits contain Medline's Red Rubber Intermittent Catheters (8Fr-22 Fr) and Red Rubber Intermittent Catheter Trays. Medline Industries, LP has identified representative samples did not meet applicable...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Medline Medical Convenience Kit Labeled As: Trach Tube Kit
Medline Industries, sold nationwide
Why: Component labeling discrepancy
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Midmark Digital Ecg Hd+12 and Midmark Iqecg Digital Ecg (2 items)
Midmark, sold nationwide
Why: A communication anomoly may result in incorrect electrocardiogram waveforms of a patient and an inaccurate beats-per-minute calculation.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Structur and Grandio Universal Nano-Hybrid Restorative Material - Capsules (2 items)
Henry Schein, sold nationwide
Why: Specific lots were distributed in the US with incorrect packaging and Instructions for Use (IFU) from the U.S. FDA-cleared device.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Conmed Linvatec Genesys Crossft Suture Anchor with Disposable Driver Ref# Cfbc
Conmed, sold nationwide
Why: Suture anchor may contain incorrect patient implant card which may result in incorrect device identification and traceability.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Healthmark Prochek-Ii and Healthmark Prochek-W Protein Test for Robotic Arms (2 items)
Healthmark Industries Co., sold nationwide
Why: Test manufactured with an expired ingredient which may present as either a false negative or positive.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Fujifilm Synapse Pacs Software V7.4.310
Fujifilm Healthcare Americas, sold nationwide
Why: Software issue may cause the ruler measurement to be inaccurate.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Philips Incisive Ct with Software V4.5&V5.0
Philips Healthcare (Suzhou) Co., sold nationwide
Why: Potential of failing to trigger clinical scan during Bolus Tracking.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Portrait Core Services Software V1.0.5 and Portrait Compute and Core Services V1.2 and 2 more (4 items)
Ge Medical Systems Information Technologies
Why: Software issue may result in a loss of patient monitoring at the Hub and Central Viewer. In addition, all alarm settings could be reset to factory defaults following the update and will not follow the alarm settings...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Drug recall, ongoing
Cyanocobalamin and Trace Elements Injection 4 and 7 more (12 products)
American Regent, sold nationwide
Cyanocobalamin 10,000 mcg/10 mL, Multrys (Trace Elements Injection 4), acetylcysteine 20%, and papaverine 60 mg/2 mL vials were recalled because particles were found. Lots 25082, 25163 and other lots, expiring 9/30/2026 to 8/31/2027, were sold nationwide in the U.S.
FDA reason: Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Class I: could cause serious harm or death
About 1.8 million people in the US are prescribed cyanocobalamin each year.
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Drug recall, ongoing
Morphine Sulfate
Fresenius Kabi USA, sold nationwide
Why: Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL, contains a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL.
Class I: could cause serious harm or death
About 590,000 people in the US are prescribed morphine each year.
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Boston Scientific Enroute Transcarotid Neuroprotection System Plus and Boston Scientific Enroute Transcarotid Neuroprotection System (2 items)
Boston Scientific, sold nationwide
Why: Potential for arterial sheath tip separation or partial tip separation during use.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Drug recall, ongoing
Carbamazepine Tablets
Golden State Medical Supply, sold nationwide
Why: CGMP deviations: tablets with black specks.
Class II: could cause temporary or reversible harm
About 420,000 people in the US are prescribed carbamazepine each year.
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Drug recall, ongoing
Carbamazepine Tablets
Sun Pharmaceutical Industries, sold nationwide
Why: CGMP Deviations; black spots found on tablets from burnt excipient during manufacturing
Class II: could cause temporary or reversible harm
About 420,000 people in the US are prescribed carbamazepine each year.
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Bmc/Reacthealth Luna G3 Apap Ref Lg
Bmc Medical Co.
Why: Retroactive reporting for 2024 rework conducted at the 3B/React Health warehouse
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Bd Needle Kit for Powered Driver
Bard Access Systems
Why: After placement of intraosseous (IO) needle sets, used when intravenous access is difficult or impossible to obtain in emergent, urgent, or medically necessary cases, users may experience difficulty/inability to remove...
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Overstitch Suture Cinch and Suture Cinch Long (2 items)
Boston Scientific, sold nationwide
Why: Device may fail to deploy the cinch implant and/or fail to cut the suture as intended.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Esteem Body Soft Convex Urostomy Pouch Model/Catalog Numbers:
Convatec, sold nationwide
Why: Urostomy Pouches may leak from cap during use.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Drug recall, ongoing
Pemetrexed Disodium (2 products)
Shilpa Medicare Limited, sold nationwide
Why: Discolored solution. The firm has received market complaints reporting green to dark green discoloration in certain vials
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Drug recall, ongoing
Cemiplimab-Rwlc
Regeneron Pharmaceuticals, sold nationwide
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
One-Piece Guedel Airway (2 items)
Intersurgical, sold nationwide
Why: Devices could potentially be occluded or partially occluded.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Drug recall, ongoing
Acamprosate Calcium Enteric-Coated
Mylan Pharmaceuticals, sold nationwide
Why: Failed Dissolution Specifications
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Halyard Lavh Pack
Avid Medical, sold nationwide
Why: The kit component was subjected to EO sterilization, contrary to the manufacturer recommendation, which may have led to the component leaking in a kit.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Beckman Coulter and Syva Emit (2 items)
Siemens Healthcare Diagnostics, sold nationwide
Why: Due to unacceptable precision performance exhibited in certain lots of the Emit 2000 Quinidine Assay, which may lead to erroneously elevated quinidine measurements, creating risk of sub-optimal patient treatment...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Blanketrol Ii Model and Blanketrol Iii and 1 more (3 items)
Gentherm Medical, sold nationwide
Why: Overheating of the 115V CPU board may cause the device to shut down.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Veritas Standard Glenoid Baseplate
Restor3d, sold nationwide
Why: Due to incorrect machining of peripheral screw hole resulting in potential for improper engagement of the peripheral screws.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Paragonix Technologies Inc. Kidneyvault Portable Renal Perfusion System Ref# Pr
Paragonix Technologies, sold nationwide
Why: Due to a firmware defect, the portable organ transfer device datalogger may lose its configuration, resulting in a blank screen and loss of displayed preservation parameters.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Td Navio Midi Speech Generating Device Model/Catalog Number: and Td Navio Maxi Speech Generating Device Model/Catalog Number: (2 items)
Tobii Dynavox, sold nationwide
Why: Under certain conditions, the battery mounting tabs may become damaged, allowing the battery to move within the device enclosure, potentially leading to an internal short circuit. This may cause localized heating and...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Hamilton Microlab Star Liquid Handler
Foundation Medicine, sold nationwide
Why: Software issue that can cause an increase in spontaneous software closures.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Cardiac Workstation (2 items)
Philips North America, sold nationwide
Why: Device will intermittently provide inaccurate data related to native heart rate.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Siemens Healthineers Immulite (2 items)
Siemens Healthcare Diagnostics Products, sold nationwide
Why: Syphilis Screen assay may contain a negative patient bias resulting in low reactive patient results being reported as nonreactive.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Endoflip System That Includes: Endoflip
Covidien, sold nationwide
Why: The system's 24-hour usage limit results in catheters incorrectly flagged as expired, making them unavailable for clinical procedures.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Beckman Coulter Dxc (2 items)
Beckman Coulter, sold nationwide
Why: a software defect in which the Parameter Package (PP) import logic overwrites all predefined calculated test rules, including those previously modified by the user, upon import of a new Parameter Package version. As a...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Fort Defiance Industries
Fort Defiance Industries, sold nationwide
Why: The Automated Field Steam Sterilizer's water recovery system 120V Amphenol connector may experience an intermittent loss of ground continuity, which could result in an unreliable fault current return path.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Arrow-Lok Implant
Arrowhead De, sold nationwide
Why: Implant did not undergo required gamma radiation dose audit. A potential reduction in sterility assurance could lead to patient infection.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Getinge Y Sensor Module
Maquet Critical Care Ab, sold nationwide
Why: The module did not undergo electrical safety tests and functional tests during production.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
American Contract Systems Medical Procedure Kits and Trays Labeled As: (2 items)
American Contract Systems
Why: The recall notice was initiated due to a Medicom Urgent Medical Device Recall. Medicom is recalling specific lots of Ritmed¿ Neurological Sponges Non-Sterile Models 55992C to 55998C due to potential for unexpected...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Arvis Surgical Navigation System Gen
Kico Knee Innovation
Why: Due to an internal sensor issue, image displayed with eyepiece may appear tilted relative to the eyepiece housing
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Minimed (3 items)
Medtronic Minimed
Why: Loaner insulin pumps may have been cleaned with chemically incompatible products that could damage the pump case or keypad, allow moisture ingress, and result in insulin over- or under-delivery, potentially causing...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Lago X and Ami Htx (2 items)
Spectral Instruments
Why: Momentary absence of On-Screen "X-Ray On" banner during run readiness check.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Dentsply Sirona Capsule Mixer Model No.
Sdi Limited
Why: Potential for electrical discharge from unit when unplugged.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Custom Made Device Implant (2 items)
Paragon 28, sold nationwide
Why: Device was recalled due to an elevated oxygen level in excess of the allowable limit. Elevated oxygen levels may contribute to reduced material ductility.
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Drug recall, ongoing
Semaglutide (11 products)
Apollo Care, sold nationwide
Apollo Care recalled semaglutide 7.5 mg, 12.5 mg, 2.25 mg and 2.5 mg sterile multi-dose vials (1.5, 5 or 2.5 mL) after finding foreign particles. Lots AC-017273, AC-017108 and other lots, expiring 8/30/2026 to 5/5/2027, were sold nationwide.
FDA reason: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Class II: could cause temporary or reversible harm
About 8.3 million people in the US are prescribed semaglutide each year.
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Drug recall, ongoing
Sildenafil Citrate USP and Tadalafil USP (5 products)
Shoolin Pharma Chem L, sold nationwide
Why: CGMP Deviations:Noted during FDA inspection
Class II: could cause temporary or reversible harm
About 1.4 million people in the US are prescribed tadalafil each year.
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Drug recall, ongoing
Glutathione
Victory Medical Center Pharmacy, sold nationwide
Why: Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.
Class I: could cause serious harm or death
About 300,000 people in the US are prescribed ascorbic acid each year.
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Drug recall, ongoing
Clindamycin Palmitate Hydrochloride
Heritage Pharmaceuticals, sold nationwide
Why: Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles.
Class II: could cause temporary or reversible harm
About 2.6 million people in the US are prescribed clindamycin each year.
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Drug recall, ongoing
Valsartan
Novartis Pharmaceuticals, sold nationwide
Why: Failed Dissolution Specifications
Class II: could cause temporary or reversible harm
About 2.6 million people in the US are prescribed valsartan each year.
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Drug recall, ongoing
Cefazolin in Dextrose
Baxter Healthcare, sold nationwide
Why: Presence of Particulate Matter
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Baxter Duo-Vent Solution Set and Male Luer Lock Adapter
Baxter Healthcare, sold nationwide
Why: Baxter received customer reports of air bubbles in the drip chamber and tubing when a pressure cuff is in use or when the tubing is flushed at the fully open position.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Drug recall, ongoing
Ioversol
Liebel-Flarsheim Company, sold nationwide
Why: Presence of Particulate Matter: comprising polyethylene and other plastic materials, stainless steel and glass.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Cardinal Health Presource Kits: (8 items)
Cardinal Health 200, sold nationwide
Why: Procedure kits contain MEDICOM Ritmed Neurological Sponges that were recalled due to unexpected variability in endotoxin levels.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
V-Loc and Surgipro Ii S8698gx Surgipro Ii Bl and 2 more (5 items)
Covidien, sold nationwide
Why: Product may contain a perforation or tear in the sterile barrier packaging. This issue may result in biocontamination of the sterile sutures, which may lead to infection, loss of vision if in ophthalmic utilization, or...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Drug recall, ongoing
Kian Pee Wan Capsules
Buy-Herbal
Why: Marketed Without an Approved NDA/ANDA: Product contains undeclared drug ingredients dexamethasone and cyproheptadine.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Medline Micro-Kill Bleach Germicidal Bleach Wipes (4 items)
Medline Industries, sold nationwide
Why: Medline Micro-Kill Bleach Germicidal Bleach Wipes may exhibit a reduction in bleach concentration to levels below specification prior to the end of the labeled 12-month shelf life. Reduced bleach concentration may...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Sodium Chloride Injection
Spectra Medical Devices
Why: Manufacturing firm, Huons, was cited for issues regarding product quality and sterility assurance. If the product sterility is compromised, patients may be exposed to microorganisms, endotoxins, or foreign matter. This...
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Boston Scientific Enhance Transcarotid/Peripheral Access Kit Ref: SR-4f21g7d-Mp
Galt Medical, sold nationwide
Why: Black depth markings may detach from the outer sheath of the coaxial dilator introducer component of transcarotid-peripheral access kits.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Obp Medical
Obp Medical, sold nationwide
Why: There is a potential for vaginal speculums to contain a burr on the proximal plastic blade, which may introduce a sharp edge in the contact regions for both the patient and the healthcare provider.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Drug recall, ongoing
Clear Eyes Maximum Itchy Eye Relief
Prestige Brands Holdings, sold nationwide
Why: Lack of assurance of sterility. The recall is due to potential contamination
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Gore Viabil Short Wire Biliary Endoprosthesis (2 items)
W L Gore & Associates, sold nationwide
Why: 10 mm diameter x 7 cm with transmural drainage holes (VSWVH1006) incorrectly labeled as 10 mm diameter x 10 cm length devices without transmural drainage holes (VSWVN1010).
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Bobby Balloon Guide Catheter Ref: Bob-895-Cn Bob-895-Emea Bob-895-Emea-Al B
Microvention, sold nationwide
Why: Due to an increase rate of balloon pinhole defects.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Allura Xper Fd. Model Numbers:
Philips Medical Systems Nederland B.V., sold nationwide
Why: Firmware issue potentially leading to loss of geometry movements.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Glidesheath Slender A-Kit
Terumo Medical, sold nationwide
Why: Product was packaged with the 0.025 guidewire instead of the 0.021 guidewire.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Navify Digital Pathology
Ventana Medical Systems, sold nationwide
Why: Due to complaints received for the Image Management System regarding image/metadata discrepancy with the Viewer window
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Thermo Fisher Diagnostics Neisseria Meningitidis Gp C
Remel Europe, sold nationwide
Why: Certain lots of Neisseria meningitidis Gp C 2ml/VL, R30166901, are not performing to IFU criteria not positive to ATCC13102 within 60 Seconds.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Erbecryo
Erbe USA, sold nationwide
Why: A strong pull on the high-pressure transfer hose of cryosurgical unit may lead to pneumatic short circuit between he gas inlet and the connector resulting in CO2 leaking into the return path, leading to excessive...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Straumann Bone Level Tapered
Straumann USA, sold nationwide
Why: Bone Level Tapered (BLT) Implant, D 4.1mm RC, SLActive 14mm, Roxolid, Loxim may inadvertently contain implants that are 12mm in length instead of 14mm as the labeling would suggest.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Xhibit Central Station
Spacelabs Healthcare, sold nationwide
Why: Due to off-the-shelf display port component that has audio/video failures
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
60 in Non-Dehp Minibore Extension Set Res Me2010 Udi-Di Code:
Bd Switzerland Sarl
Why: Products may not have received adequate sterilization processing.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Gm Helix Implant
Straumann USA, sold nationwide
Why: There may be a mismatch between the implant contained inside the packaging and the information described on the outer carton label. If the the incorrect implant is installed, the issue could cause bone compression or...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Biofire Respiratory Panel
Biofire Diagnostics, sold nationwide
Why: Due to increase in false negative results
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Philips Azurion Rystem
Philips Medical Systems Nederland B.V.
Why: Two software related issues affecting Azurion R2.2.10 Systems: 1) Potential image quality degradation that may lead to delay of therapy, procedural complications and/or inappropriate treatment and 2) Potential loss of...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Philips Azurion
Philips Medical Systems Nederland B.V.
Why: Two software related issues: 1) Potential image quality degradation that may lead to delay of therapy, procedural complications and/or inappropriate treatment and 2) Potential loss of geometry movements that may lead to...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Endo-Model
Waldemar Link Gmbh & Co. Kg (Mfg Site)
Why: The affected Endo-Model replacement set for a Rotating Hinge tibial plateau incorrectly contains a Pure Hinge plateau. The incorrect plateau could lead to a prolonged or modified surgery as the plateau cannot be...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Pronephro Aki
Bioporto Diagnostics A/S
Why: The use of a non-validated rework process for assay reagents which could lead to missed diagnosis of renal disease, inappropriate treatment decisions, or inappropriate monitoring of renal disease in intended users.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab)
Current drug shortages
68 drugs
| Drug | Status | Updated | Reason | Category |
|---|---|---|---|---|
| Amino Acid Injection | Current | Nov. 10, 2026 | Shortage of an active ingredient | Gastroenterology |
| Dextrose Monohydrate 5% Injection | Current | Nov. 10, 2026 | Demand increase for the drug | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Dextrose Monohydrate 70% Injection | Current | Nov. 10, 2026 | Not stated | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Lidocaine Hydrochloride Injection | Current | Nov. 10, 2026 | Other | Cardiovascular |
| Sterile Water Irrigant | Current | Nov. 10, 2026 | Discontinuation of the manufacture of the drug | Gastroenterology, Other, Pediatric |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Current | Nov. 9, 2026 | Other | Psychiatry |
| Atropine Sulfate Injection | Current | Nov. 9, 2026 | Other | Anesthesia, Neurology, Pediatric |
| Bupivacaine Hydrochloride Injection | Current | Nov. 9, 2026 | Other | Anesthesia |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Current | Nov. 9, 2026 | Other | Anesthesia |
| Carboplatin Injection | Current | Nov. 9, 2026 | Other | Oncology |
| Clindamycin Phosphate Injection | Current | Nov. 9, 2026 | Discontinuation of the manufacture of the drug | Anti-Infective |
| Dobutamine Hydrochloride Injection | Current | Nov. 9, 2026 | Other | Cardiovascular, Pediatric, Renal |
| Dopamine Hydrochloride Injection | Current | Nov. 9, 2026 | Other | Cardiovascular |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Current | Nov. 9, 2026 | Other | Anesthesia, Pediatric |
| Fentanyl Citrate Injection | Current | Nov. 9, 2026 | Demand increase for the drug | Analgesia/Addiction, Pediatric |
| Furosemide Injection | Current | Nov. 9, 2026 | Other | Cardiovascular |
| Heparin Sodium Injection | Current | Nov. 9, 2026 | Other | Hematology |
| Hydromorphone Hydrochloride Injection | Current | Nov. 9, 2026 | Other | Analgesia/Addiction |
| Ketorolac Tromethamine Injection | Current | Nov. 9, 2026 | Other | Analgesia/Addiction |
| Lorazepam Injection | Current | Nov. 9, 2026 | Demand increase for the drug | Neurology |
| Meperidine Hydrochloride Injection | Current | Nov. 9, 2026 | Not stated | Analgesia/Addiction |
| Methotrexate Sodium Injection | Current | Nov. 9, 2026 | Other | Rheumatology, Oncology |
| Midazolam Hydrochloride Injection | Current | Nov. 9, 2026 | Other | Anesthesia, Neurology |
| Morphine Sulfate Injection | Current | Nov. 9, 2026 | Other | Analgesia/Addiction |
| Rocuronium Bromide Injection | Current | Nov. 9, 2026 | Delay in shipping of the drug | Anesthesia |
| Sodium Acetate Injection | Current | Nov. 9, 2026 | Other | Endocrinology/Metabolism, Gastroenterology, Pediatric, Total Parenteral Nutrition |
| Sodium Bicarbonate Injection | Current | Nov. 9, 2026 | Other | Endocrinology/Metabolism, Gastroenterology, Pediatric |
| Sterile Water Injection | Current | Nov. 9, 2026 | Demand increase for the drug | Other |
| Sufentanil Citrate Injection | Current | Nov. 9, 2026 | Other | Analgesia/Addiction, Pediatric |
| Dexmedetomidine Hydrochloride Injection | Current | Nov. 6, 2026 | Other | Anesthesia |
| Dextrose Monohydrate 50% Injection | Current | Nov. 6, 2026 | Demand increase for the drug | Endocrinology/Metabolism, Gastroenterology, Pediatric |
| Methylprednisolone Acetate Injection | Current | Nov. 6, 2026 | Demand increase for the drug | Rheumatology |
| Penicillin G Benzathine Injection | Current | Nov. 6, 2026 | Other | Anti-Infective |
| Rifampin Injection | Current | Nov. 6, 2026 | Discontinuation of the manufacture of the drug | Anti-Infective |
| Quinapril Hydrochloride Tablet | Current | Nov. 4, 2026 | Discontinuation of the manufacture of the drug | Cardiovascular |
| Quinapril/Hydrochlorothiazide Tablet | Current | Nov. 4, 2026 | Discontinuation of the manufacture of the drug | Cardiovascular |
| Azacitidine Injection | Current | Nov. 3, 2026 | Discontinuation of the manufacture of the drug | Oncology |
| Cromolyn Sodium Concentrate | Current | Nov. 3, 2026 | Other | Pulmonary/Allergy |
| Dexamethasone Sodium Phosphate Injection | Current | Nov. 3, 2026 | Demand increase for the drug | Dermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Other, Pulmonary/Allergy, Rheumatology |
| Dextrose Monohydrate 10% Injection | Current | Nov. 3, 2026 | Demand increase for the drug | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Etomidate Injection | Current | Nov. 3, 2026 | Other | Anesthesia |
| Ifosfamide Injection | Current | Nov. 3, 2026 | Demand increase for the drug | Oncology, Pediatric |
| Lisdexamfetamine Dimesylate Capsule | Current | Nov. 3, 2026 | Shortage of an active ingredient | Psychiatry |
| Methylphenidate Hydrochloride Tablet, Extended Release | Current | Nov. 3, 2026 | Discontinuation of the manufacture of the drug | Psychiatry |
| Metronidazole Injection | Current | Nov. 3, 2026 | Other | Anti-Infective |
| Propranolol Hydrochloride Injection | Current | Nov. 3, 2026 | Delay in shipping of the drug | Cardiovascular |
| Remifentanil Hydrochloride Injection | Current | Nov. 3, 2026 | Delay in shipping of the drug | Analgesia/Addiction |
| Rifampin Capsule | Current | Nov. 3, 2026 | Discontinuation of the manufacture of the drug | Anti-Infective |
| Ropivacaine Hydrochloride Injection | Current | Nov. 3, 2026 | Delay in shipping of the drug | Anesthesia |
| Valproate Sodium Injection | Current | Nov. 3, 2026 | Demand increase for the drug | Neurology |
| Echothiophate Iodide Ophthalmic Solution | Current | Nov. 2, 2026 | Not stated | Ophthalmology |
| Hydroxocobalamin Injection | Current | Nov. 2, 2026 | Other | Other |
| Lisdexamfetamine Dimesylate Tablet, Chewable | Current | Nov. 2, 2026 | Not stated | Psychiatry |
| Streptozocin Powder, For Solution | Current | Nov. 2, 2026 | Other | Oncology |
| Technetium TC-99M Pyrophosphate Kit Injection | Current | Nov. 2, 2026 | Shortage of an active ingredient | Medical Imaging |
| Furosemide Oral Solution | Current | Oct. 27, 2026 | Not stated | Cardiovascular |
| Bacitracin Ophthalmic Ointment | Current | Oct. 23, 2026 | Discontinuation of the manufacture of the drug | Anti-Infective, Ophthalmology |
| Pentostatin Injection | Current | Oct. 21, 2026 | Other | Oncology |
| Methylphenidate Film, Extended Release | Current | Oct. 16, 2026 | Not stated | Psychiatry |
| Conivaptan Hydrochloride Injection | Current | Oct. 15, 2026 | Delay in shipping of the drug | Cardiovascular |
| Desmopressin Acetate Spray | Current | Oct. 15, 2026 | Delay in shipping of the drug | Hematology |
| Riluzole Oral Suspension | Current | Oct. 15, 2026 | Requirements related to complying with good manufacturing practices | Neurology |
| Cefotaxime Sodium Powder, for Solution | Current | Oct. 14, 2026 | Demand increase for the drug | Anti-Infective, Pediatric |
| Liraglutide Injection | Current | Oct. 14, 2026 | Discontinuation of the manufacture of the drug | Endocrinology/Metabolism |
| Promethazine Hydrochloride Injection | Current | Oct. 14, 2026 | Demand increase for the drug | Analgesia/Addiction, Gastroenterology, Pediatric, Pulmonary/Allergy |
| Flurazepam Hydrochloride Capsule | Current | Sept. 15, 2026 | Regulatory delay | Neurology, Other |
| Triamcinolone Hexacetonide Injection | Current | Sept. 15, 2026 | Not stated | Rheumatology |
| Isocarboxazid Tablet | Current | Aug. 6, 2026 | Other | Psychiatry |
Sources: openFDA recall and shortage records (opens in a new tab)